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Ablation procedures
See also Catheters; Lasers
Balloon electric shock ablation (BESA)-
chronic effect on ventricular structure
and electrophysiology, 250A
Catheter-mediated electrical ablation of
posterior septal accessory pathways:
complications and effectiveness, 250A
Transcatheter electrical ablation of accessory
pathways in children, 36A
Accessory atrioventricular pathways
See also Wolff-Parkinson-White syndrome
Atrial fibrillation in patients with accessory
pathways: differences between patients
with the Wolff-Parkinson-White
syndrome and those with concealed
accessory pathways, 12A
Concealed accessory pathways: prevention
of preexcitation by permanent antegrade
block at the ventricular insertion of the
accessory pathway, 13A
The physiologic substrate for antidromic
reciprocating tachycardia: prerequisite
characteristics of the accessory pathway
and atrioventricular node. 12A
Total atriotomy improves results of
transection of multiple accessory
pathways. IOOA
Acetylcholine
Coronary angiographic and hemodynamic
effects of intracoronary injection of
acetylcholine in humans, 193A
Acquired immunodeficiency syndrome
AIDS-associated heart disease: is it a
distinct entity", 220A
Patients with the acquired immunodeficiency
syndrome and histopathological
myocarditis frequently manifest major
clinical cardiac abnormalities, 154A
Action potentials
Abnormal action potentials and calcium
handling in myopathic hyman
myocardium, I72A
Class III antiarrhythmic agents do not alter
recovery of premature action potential
duration in dog Purkinje fibers, 156A
The map field of view: implications for
recording focal phenomena, 253A
Protein kinase C induced calcium-dependent
slow action potentials in rat atrial
myocytes, 209A
Acute myocardial infarction
See Myocardial infarction, acute
Adenosine
Adenosine stimulates carotid body
chemoreceptors in man, 137A
Intracoronary adenosine markedly reduces
infarct size and improves ventricular
function in a canine reperfusion model,
126A
Adenosine triphosphate
Absence of arachidonic acid metabolism in
adenosine triphosphate depleted cardiac
myocytes, 186A
Disparate effects of adenosine triphosphate
on sinus node automaticity and AV
nodal conduction in man, 246A
Postischemic ATP levels fail to correlate
with regional functional recovery after
surgical revascularization of acute
infarction, 89A
Adenylate cyclase
Effect of acute ischemia and reperfusion on
myocardial l3-adrenoreceplOrs and
adenylate cyclase activity, 80A
Reconstitution of muscarinic cholinergic
inhibition of adenylate cyclase activity
in embryonic chick heart, 134A
The vasoactive intestinal peptide receptor is
coupled to adenylate cyclase and
muscle contraction in human ventricular
myocardium, l37A
Adriamycin
Effect of adriamycin on heart mitochondrial
DNA synthesis, 38A
The importanceof diastolic dysfunction in
the development of clinically significant
adriamycin cardiotoxicity, 42A
Afterload
See Loading conditions
AIDS
See Acquired immunodeficiency syndrome
Alcohol
See also Ethanol
Alcohol and stroke, 78A
Effect of alcohol on diurnal heart rate
variation, 225A
Allopurinol
Myocardial function preserved by
allopurinol given systematically or in
cardioplegic solution, 88A
Alpha-adrenergic blockade
Differing effects of a I-adrenergic blockade
with prazosin and indoramin on
coronary flow during exercise, 255A
Alpha-adrenergic receptor
Increase in epinephrine induced platelet
aggregation with adverse kinetics of
platelet adrenergic receptor in patients
with ischemic heart disease, 240A
Selective alpha and beta adrenergic
regulation of pulmonary intravascular
volume, 170A
Ambulatory electrocardiography
Accuracy and reproducibility of Holter
recordings in the cardiac arrhythmia
pilot study, 207A
Early detection of silent ischemia using
ambulatory monitoring and intervention
to reduce ischemic burden, 207A
Features of ischemia during daily activities
in patients with and without previous
myocardial infarction, 241A
Prognostic significance of ischemic episodes
on Holter monitoringduring daily
activities: 2 years follow-up of 356
patients, 240A
Qualificationrates of various Holter
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monitoring criteria in patients with
ventricular tachycardias, 97A
Use of one hour ECG recordings to identify
patients with ventricular ectopy post
infarction and to assess therapy, 220A
Aminophylline
Lowering of cardiac defibrillation threshold
by aminophylline in the conscious dog,
142A
Amiodarone
Amiodarone-associated neutrophil
inclusions, 48A
Amiodarone-a use dependent calcium
channel blocker, 50A
Amiodarone binds to the type I
antiarrhythmic drug receptor on the
cardiac sodium channel. 50A
The amiodarone hump: recurrent sustained
ventricular tachycardia during loading.
47A
Amiodarone induced slowing of ventricular
tachycardia: insights from analysis of
resetting response patterns. 48A
Amiodarone therapy in cardiac and
noncardiac surgery, 90A
Anti-arrhythmic effects of
desethylamiodarone and amiodarone
against reperfusion-induced arrhythmias
in the anesthetized rat, 51A
Calcium channel blocking properties of
amiodarone,51A
A comparison of the acute
electrophysiologic and antiarrhythmic
effects of amiodarone and
desethylamiodarone, 50A
Factors predicting safe early hospital
discharge after treatment of ventricular
tachycardia or ventricular fibrillation
with amiodarone, 47A
A rnulticenter, randomized trial on the
efficacy of amiodarone, flecainide ,
propafenone in patients with cardiac
disease and complex ventricular
arrhythmias, 48A
Neurophysiologic and pathologic evaluation
of amiodarone induced neuropathy,
48A
Pharmacokinetic interaction between
amiodarone and phenytoin. 47A
The time course of the reduction of
ventricular arrhythmias during oral
amiodarone loading, 47A
Amrinone
Direct vasodilatory action of amrinone
demonstrated in calves with artificial
hearts, 133A
Failure of intravenous amrinone to improve
renal hemodynamics and neurohumoral
status in patients with severe chronic
heart failure, 103A
Amyloidosis
See Cardiac amyloidosis
Ancrod
Ancrod enhances the thrombolytic effect of
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urokinase and recombinant tissue-type
plasminogenactivator, l34A
Aneurysms
See also Ventricularaneurysm
Atherosclerotic aneurysm of aorto-coronary
vein graft as a cause of recurrent
myocardial ischemia, 148A
Hypertension and late survival in aneurysm
patients, 114A
Angina pectoris
Angina with normal angiograms: a disorder
involving the entire coronary tree
vasodilation, l76A
Antiischaemic activity of ACE-inhibitor
Enalapril in normotensive patients with
stable effort angina, I92A
A comparison of celiprolol to propranolol in
angina pectoris: results of an
international double-blind study, 192A
Coronary morphology demonstrates a
common link between unstable angina
and non-Q wave infarction, 196A
Correlation with (3 endorphin blood levels
and anginal pain in patients with
coronary artery disease, 176A
Detection of subendocardial ischemia by
recording endocardial electrograms
during pacing induced angina, 70A
Duration of effects of isosorbide-5-
monotritrate in angina pectoris, 134A
Early and long-term outcome after PTCA in
stable versus unstable angina, 150A
Effects of completeness of revascularization
on outcome in patients with unstable
angina undergoing percutaneous
transluminal coronary angioplasty,
150A
Effects of diltiazem, nifedipine, and their
combination on transient ST-segment
deviations on the ambulatory ECG in
patients with stable angina pectoris,
I77A
Efficacy of pentoxifylline in chronic stable
angina pectoris, 176A
Factors influencing the long-term (five year)
prognosis of patients with variant
angina, 150A
Fibrin degradation products in ischemic
heart disease: non invasive evidence of
spontaneous fibrinolysis in unstable
angina, 239A
Multivessel coronary angioplasty for
unstable versus stable angina: long-term
clinical and angiographic results, l83A
Poor predictive value of the London School
of Hygiene Cardiovascular(Rose)
Questionnaire for the diagnosis of
angina pectoris compared to thallium-
201 imaging, 78A
A randomized, placebo-controlled trial of
recombinant tissue-type plasminogen
activator (rt-PA) for unstable angina,
239A
The results of percutaneous transluminal
coronary angioplasty for unstable
angina in the elderly, 150A
A simple clinical angina score stratifies
prognosis in patients with documented
coronary disease, 175A
Surgical treatment of progressive rest angina
pectoris: multivariate stepwise
discriminant analysis of factors
influencing ten year survival, 87A
Twelve year follow-up of patients with
unstable angina pectoris randomized to
medical or surgical therapy, 149A
Unstable angina-changing clinical,
anatomic and therapeutic aspects, 182A
Angiography
See also Arteriography
Accuracy of angiography in subclassifying
critical coronary arterial stenosis:
implications for balloon angioplasty,
179A
The accuracy of coronary lumen quantitation
by rapid, on-line digital angiographic
methods, 44A
Angiography of the "supply vessel" in
multivessel coronary artery disease,
22lA
Angiography in evolution: six years of
changing indications, success and risks,
181A
Blood velocity measurements during
selective coronary angiography before
and after percutaneous transluminal
coronary angioplasty, 70A
Comparison of positron tomography and
quantitative angiography in stenosis
analysis after acute thrombolysis and
angioplasty in evolving myocardial
infarction, 179A
Correlation of digital angiographic with
Doppler estimation of coronary flow
reserve, 161 A
Digital angiographic determination of
absolute coronary blood flow, 161 A
Digital angiographic transfer function
analysis of myocardial flow and
coronary reserve: comparison with
conventional time-density curve
parameters, 44A
Digital subtraction angiography flow reserve
imaging-validation of a flow model
and volume parameters, 44A
An electronic caliper method of quantitative
coronary angiography, 179A
Percutaneous brachial artery approach to
coronary angiography, a safe alternative
to femoral artery catheterization, l78A
Quantitative angiographic morphology of the
coronary artery lesions at risk, for
thrombotic occlusion, 238A
Selection of patients for coronary
angiography following acute myocardial
infarction, 193A
Serial angiography analysis of ventricular
function recovery after intracoronary
streptokinase, 61A
Angiography, radionuclide
See also Iridium-191 m; Thallium-20I;
Ventriculography, radionuclide
Comparisonof measurements of left
ventricular function during exercise by
first-pass and equilibrium techniques,
4A
Early radionuclide angiography identifies
low risk patients for late restenosis after
transluminal coronary angioplasty, 5A
Estimation of valve area in patients with
aortic valve disease by Doppler
echocardiography and radionuclide
angiography, 235A
Peak filling rate by radionuclide
angiography: effect of normalization
parameters, 4A
Angioplasty, balloon
Accuracyof angiography in subclassifying
critical coronary arterial stenosis:
implications for balloon angioplasty,
179A
Balloon angioplasty for native coarctation of
the aorta: long term results, l29A
Balloondilatation angioplasty for unoperated
coarctation of the aorta in children: 2
year follow-up and late sequelae, 132A
Double balloon technique for dilatation of
valvular or vessel stenosis in congenital
and acquired heart disease, 76A
Intermediate follow up of balloon dilatation
angioplasty of native coarctation, 75A
Intraoperative balloon angioplasty of aortic
coarctation, 131 A
Long-term results of percutaneous balloon
angioplasty (PBA) for native
coarctation, 75A
Multivariate analysis of factors predicting
improvement in regional wall motion
following direct balloon angioplasty in
acute myocardial infarction, 233A
Angioplasty, coronary
See also Lasers; Restenosis;
Revascularization
Abrupt recurrent thrombosis after
intravenous tissue plasminogen
activator and emergency coronary
angioplasty in acute myocardial
infarction, 232A
Abrupt reocclusion in PTCA: angiographic
characteristics and clinical
consequences, 181 A
Apparent symptom-related lesion recurrence
in multivessel coronary disease patients:
does the number of lesions dilated
make a difference", l85A
Blood velocity measurement during selective
coronary angiography before and after
percutaneous transluminal coronary
angioplasty, 70A
Clinical and anatomic descriptions for a
major complication following PTCA,
20A
Clinical course of patients treated with
emergency PTCA for acute MI, 192A
Comparisonof current and earlier
complications of angioplasty: NHLBI
PTCA Registry, 19A
Complete vs. incomplete revascularization in
multivessel disease: a report from the
NHLBI PTCA Registry, 15A
Completenessof revascularization early after
coronary angioplasty (PTCA) in the
NHLBI PTCA Registry, 19A
Coronary angioplasty following rt-PA in
acute myocardial infarction: a report
from the thrombolysis in myocardial
infarction (T1MI) trial, 231A
Coronary angioplasty of a "culprit" lesion
in patients with multivessel coronary
disease, 16A
Determinants of left ventricular function
after emergent interventional therapy in
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myocardial infarction: the role of
residual stenosis. 233A
Direct angioplasty in acute myocardial
infarction-benefit of late reperfusion
in patients with collateral flow. 191 A
Does clinical indication for coronary
angioplasty affect outcome? 182A
Dopplerevaluation of left ventricular
diastolic filling function during
angioplasty. 213A
Dynamic angioplasty as a treatment
modality in peripheral vasculardisease:
the first clinical results. 180A
Early angiographic changes after
percutaneous transluminal coronary
angioplasty, 181 A
Early and long-term outcome after PTCA in
stable versus unstable angina. 150A
Effect of clinical status after failed
angioplasty on surgical morbidity and
mortality. 88A
Efficacy of angioplasty in patients with prior
bypass surgery. 183A
Efficacy of coronary angioplasty for patients
with multivessel coronary artery
disease: clinical status at six months of
follow-up. 15A
Emergency coronary angioplasty therapy for
elderly patients with acute myocardial
infarction: cautionary results. 232A
Evaluation of left ventriculardiastolic fill ing
during coronary angioplasty using
Dopplerechocardiography. 213A
Event free survival after successful
angioplasty in multivessel coronary
artery disease. 15A
Followup of successful multivessel coronary
disease angioplasty patients: is success
sustained? 185A
Frequency of coronary reocclusion after
successful intracoronary thrombolysis in
acute myocardial infarction: comparison
of immediate PTCA with subsequent
medical treatment. 232A
Gated digital roadmapping: a new computer-
based imaging support system for
coronary angioplasty, 70A
Ibuprofen: a potent antithrombotic agent for
arterial injury after balloon angioplasty,
64A
Impact of distal coronary perfusion on
ejection fraction response to balloon
inflation during PTCA. 69A
In-vivo validation of an automatic coronary
quantitation program for on-line use
during angioplasty. 44A
Morbidity and mortality associated with
emergency bypass graft surgery
following elective coronary angioplasty.
124A
Mortality of acute closure following
coronary angioplasty (PTCA). 20A
Multicenter study of percutaneous
transluminal angioplasty for right
coronary artery stenosis. 20A
Multivessel coronary angioplasty: long-term
clinical and angiographic follow-up.
184A
Multivessel coronary angioplasty for
unstable versus stable angina: long-term
clinical and angiographic results. 183A
Observer variability of quantitative coronary
arteriography pre- and post-coronary
angioplasty: superiority of absolute
diameter measurements. 45A
Percutaneous transluminal coronary
angioplasty: relationship between
restenosis and inflation times. 64A
Percutaneous transluminal coronary
angioplasty: techniques and results in
anomalous aortic origin of the coronary
arteries. 181A
PTCA in 1985: NHLBI PTCA Registry.
19A
Quantitation of lumen enlargement during
coronary angioplasty using pressure-
volume curves vs. arteriography. 105A
A randomized, multicenter trial of
intravenous plasminogen activator and
emergency coronary angioplasty in
acute myocardial infarction: results
from the TAMI Study Group. 231A
Removal of angioplasty debris from the
coronary and systemic arterial
circulation-is it necessary? 107A
Residual stenosis following coronary
angioplasty: effects on symptoms.
myocardial perfusion and LV function.
180A
The resultsof percutaneous transluminal
coronary angioplasty for unstable
angina in the elderly. 150A
Resultsof PTCA in women in 1985. 56A
Staged percutaneous transluminal coronary
angioplasty (PTCA) in patients with
multivessel disease: use of stress Tt -I
imaging, 26A
Success of coronary angioplasty (PTCA) in
treating segmental stenosis with length
greater Ihan Iflmm, 182A
Symptomatic and silent reocclusion
following combinedstreptokinase and
successful coronary angioplasty in acute
myocardial infarction. 173A
Transluminal angioplasty in renovascular
disease: long-term followup, 114A
Treatmentof acute myocardial infarction
with emergency coronary angioplasty,
232A
Angioseope
Direct observation of coronary thrombus
using a newly developed ultrathin
(1.2mm) flexible angioscope, 197A
Angioscopy
Angioscopy guided coronary thrombolysis.
62A
Coronaryangioscopy: the spectrum of
disease in the first 100 patients. 197A
Anipamil
Protective effect of pretreatment with
anipamil in the ischernic-reperfused rat
heart. 72A
Anuloplasty
Recent improvement in late survival after
double valve replacement and tricuspid
anuloplasty.9lA
Anomalous arteries
Detachable latex balloonocclusionof
anomalous systemic arteries in patients
with tetralogyof Fallot. 13IA
Percutaneous transluminal coronary
angioplasty techniques and results in
anomalous aortic origin of the coronary
arteries. 181 A
Antiarrhythmic drugs
See also specific agent
Absence of changes in body surface maps of
signal-averaged late activity in patients
with ventricular tachycardia after
antiarrhythmic drugs. 152A
Can results of antiarrhythmic drug trials
using programmed extrastimulus
techniques be reproduced in patients
with sustained ventricular
tachyarrhythmias? 97A
Class III antiarrhythmic agents do not alter
recovery of premature action potential
duration in dog Purkinje fibers, 156A
Differential effects of class I and class III
antiarrhythmic drugs on reentry in
chronic canine model of atrial flutter.
156A
Do baselineclinical characteristics predict
initial response to antiarrhythmic
therapy? 71A
Incidence of ventricular tachycardia or
ventricular fibrillation or proarrhythmic
effects of drug treatmentof ventricular
arrhythmias, 245A
A model for frequency dependent depression
on maximal uptake velocity by type I
antiarrhythmic drugs. 155A
A placebo-controlled study of the
proarrhythmic effects of class I
antiarrhythmic drugs. 245A
Anti-platelet agents
See also specific agents
Effect of antiplatelet therapy on early graft
patency after coronary artery bypass
grafting: VA cooperative study #207.
125A
The effect of marine oil in conjunction with
other antiplatelet agents on bleeding
time and plasma lipids, 185A
Aortic disease
Assessment of aortic disease by ultrafast
computed tomography. 159A
Aortic function
Use of exercise Doppler to evaluate cardiac
drugs: comparative influence of beta
and calcium blockerson aortic
acceleration and velocity. 18A
Aortic insufficiency
An experimental plea for the use of
nitroglycerin in the treatment of acute
aortic insufficiency. 84A
Quantification of aortic insufficiency using
color Doppler flow imaging, 66A
Quantitative assessment of aortic
insufficiency by color Doppler. 66A
Regional variation in myocyte diameter: a
clue to early left ventriculardysfunction
in aortic insufficiency. 22A
Aortic regurgitation
The beneficial hemodynamic effect of rapid
atrial pacing in severe acute-aortic
regurgitation (AR). 84A
Cardiac cine magnetic resonance imaging:
detection of mitral and aortic
regurgitation. 159A
Comparison of two Doppler methods for
evaluatingaortic regurgitation, 238A
The curvilinear relation between aortic
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regurgitanl fraction and color flow jets:
intraoperative 2-dimensional Doppler
and electromagnetic flowmeter
correlation. 66A
Early diastolic interaction between the aortic
regurgitant jet and mitral inflow. A
pulsed Doppler study. 83A
Natural history of chronic asymptomatic or
minimally symptomatic aortic
regurgitation.2lA
Noninvasive quantification of aortic
regurgitant area utilizing Doppler half-
time analysis. 237A
Aortic stenosis
Accuracy of Doppler in predicting severity
of aortic stenosis; a practical
application of the continuity equation.
21A
Aid of echocardiography in balloon
valvuloplasty for aortic stenosis and
mitral stenosis. 217A
Antegrade balloon valvotomy for aortic
stenosis. 14A
Balloon aortic valvuloplasty in adult patients
with calcific aortic stenosis: acute and
follow-up studies. 13A
Balloon valvuloplasty for isolated aortic
stenosis in children-short term results.
130A
Can the modified Bernoulli equation be used
to accurately determine intraventricular
pressure throughout systole in patients
with valvular aortic stenosis? 236A
Color Doppler assessment of aortic valve
stenosis. 65A
Evaluation of left ventricular diastolic filling
in isolated aortic stenosis using Doppler
echocardiog raphy, 17A
Percutaneous balloon aortic valvuloplasty in
elderly patients with severe calcific
aortic stenosis who are poor candidates
for valve replacement surgery. 83A
Percutaneous balloon valvuloplasty in
elderly patients with aortic stenosis and
low ejection fraction. 195A
Percutaneous transluminal valvuloplasty in
adult aortic stenosis: results in 130
patients. I3A
Prediction of severity of aortic stenosis by
simple Doppler velocity measurements:
correlation with CATH in 100 patients.
256A
Simplification of the Doppler continuity
equation for calculating stenotic aortic
valve area. 236A
Treatment of calcific aortic stenosis by
balloon valvuloplasty. 13A
Aortic valve disease
Estimation of valve area in patients with
aortic valve disease by Doppler
echocardiography and radionuclide
angiography. 236A
Incremental value of clinical examination.
echocardiography and cardiac
catheterization in the evaluation of
aortic valve disease. 20A
Apolipoprotein
Changes in apolipoprotein and HDL
subtraction levels following partial ileal
bypass: POSCH 5-year results. 54A
High density-lipoprotein and apolipoprotein
A-I levels in children: interrelationship
and correlates in the Bogalusa Heart
Study.55A
Apoproteins
The ratio of apoprntein B to apoprotein A-I
as the best predictor of premature
coronary artery disease in women. 54A
APSAC
A randomized placebo-controlled dose-
response study with the thrombolytic
agent APSAC (BRL 26<)2 1) in acute
coronary artery occlusion. 135A
Residual stenosis in evolving myocardial
infarction/a randomized study of
APSAC v. streptokinase. 23lA
Arachidonate
Oxygen free radicals mediate arachidonate
induced platelet aggregation and
thromboxane B2 production. 2A
Subcellular distribution and potential loci of
release of arachidonate: implications for
myocardial ischemic injury. 38A
Arachidonic acid
Absence of arachidonic acid metabolism in
adenosine triphosphate depleted cardiac
myocytes, 186A
Piriprost (U-60.257B) modulates eicosanoid
formation and reduces myocardial
neutrophil accumulation in infarct size
in rats. 80A
Arrhythmias
See also Ventricular arrhythmias
Arrhythmias provoked by exercise stress
testing are independent of clinical
characteristics of patients with
ventricular tachyarrhythmias. 1<)5A
Atrial activity during cardioplegia and
postoperative arrhythmias. 7A
Effect of isoproterenol on atrial latency and
atrial arrhythmias, 10l A
Lack of specificity of early post
thrombolytic arrhythmias as a
reperfusion marker in acute myocardial
infarction. 191 A
Predictorsof arrhythmic recurrence in
survivors of ventricular fibrillation
rendered free of inducible ventricular
tachycardia. 97 A
Reproducibility of arrhythmia induction in
the absence of antiarrhythmic
medications. I09A
Arrhythmias, pediatric
Cardiac Doppler flows during fetal
dysrhythmias: studies of post
extrasystolic potentiation and recovery
from tachycardia. 35A
Effect of propranolol and verapamil during
infant orthodromic reciprocating
tachycardia. 36A
The electrophysiologic effects of
propafenone on the immature
mammalian heart. 36A
Epicardial ventricular pacemaker lead
longevity in children. 37A
Only 8% of post operative tetralogy patients
have inducible ventricular
dysrhythmias, 36A
Transcatheter electrical ablation of accessory
pathways in children. 36A
Arterial system
Ventriculo-arterial interaction in normal and
failing heart in man. 7A
Arteriography
Accuracy of coronary artery stenosis
quantitation by digital subtraction
coronary arteriography: an in vivo dog
model. 45A
Observer variability of quantitative coronary
arteriography pre- and post-coronary
angioplasty: superiority of absolute
diameter measurements. 45A
Artificial heart
The artificial heart: bridge to cardiac
transplantation. 28A
Intact atrial endocrine function in humans
with the permanently implanted
artificial heart. 248A
Reducing hemolysis and stroke
complications in human recipients of
the Jarvik-7 total artificial heart: a
report of fifteen patients. 28A
Summary of the world experience with
clinical use of total artificial hearts as
cardiac support devices. 28A
Aspirin
Effect of antiplatelet therapy on early graft
patency after coronary artery bypass
grafting: VA cooperative study. 125A
The effect of marine oil in conjunction with
other antiplatelet agents on bleeding
time and plasma lipids, 185A
Lack of antithrombotic efficacy of high dose
aspirin relative to low dose aspirin is
restored by PGb infusion. 136A
Synergistic inhibitory effects of aspirin and
ethanol on epinephrine exacerbation of
acute coronary thrombus formation in
stenosed dog coronary arteries. 189A
Unanticipated effects of aspirin on
lymphokines, 135A
Atenolol
A comparison of atenolol and sotalol in the
treatment of patients with paroxysmal
supraventricular tachycardia, 247A
Atherosclerosis
Atherosclerosis determines the response of
coronary arteries to cold pressor
stimulation. 69A
Atherosclerotic arteries produce more
prostacyclin and thromboxane than
normal arteries. 170A
Deposition of silver-hematoporphyrin in
atherosclerotic plaque is homogenous.
intercellular and confined to plaque.
178A
Vasodilating ability of severely
atherosclerotic coronary arteries:
evaluation by epicardial
echocardiography in the operating
room. IS7A
Vasoreactivity in isolated perfused
atherosclerotic human coronary arteries.
254A
Videomicroscopic demonstration of
defective cholinergic arteriolar
vasodilation in atherosclerotic rabbit,
21lA
Atrial activity
Atrial activity during cardioplegia and
postoperative arrhythmias, 7A
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Atrial fibrillation
Atrial fibrillation in patients with accessory
pathways: differences between patients
with the Wolff-Parkinson-White
syndrome and those with concealed
accessory pathways, I2A
Atrial fibrillation and systemic embolization:
left atrial size strongly predicts risk of
embolization in patients without mitral
stenosis, 220A
Atrial natriuretic factor in atrial fibrillation
and during supraventricular tachycardia,
33A
Clinical and echocardiographic variables for
predicting short and long-term success
after cardioversion of atrial fibrillation,
241A
Coronary effects of atrial fibrillation
analyzed by pressure-flow relations,
92A
Flecainide acetate-an effective drug in
paroxysmal atrial fibrillation, 247A
Managementof atrial fibrillation in
hypertrophic cardiomyopathy, 117A
Atrial flutter
Differential effects of class I and class 1II
antiarrhythmicdrugs on reentry in
chronic canine model of atrial flutter,
156A
Double-spike electrograms in atrial flutter:
validation as a marker of local atrial
conduction delay, 153A
Incidence and patterns of resetting during
atrial fluller: role in identifying
chamber of origin, 153A
Atrial natriuretic factor
Acute increase of right atrial pressure by
intracardiac stimulation releases atrial
netriuretic peptide (ANP), 247A
Atrial natriuretic factor during exercise in
human subjects, 234A
Atrial natriuretic factor has no direct effect
in myocardial contractility, 170A
Atrial natriuretic factor in atrial fibrillation
and supraventricular tachycardia, 33A
Atrial natriuretic factor is a marker for
cardiac volume overload in humans
with asymptomatic left ventricular
dysfunction, 117A
Atrial natriuretic peptide in experimental
heart failure: atrial content, plasma-
levels and effects of volume loading,
119A
Atrial natriuretic peptide produces favorable
hemodynamic changes and increases
sodium excretion in congestive heart
failure (CHF), 119A
Atrial natriuretic peptide released by rapid
atrial pacing is associated with
suppression of plasma renin activity,
17IA
Cardiovascular-renal responses to
physiologicconcentrationsof atrial
natriuretic factor (ANF), 242A
Early and late effects of percutaneous
balloon mitral valvuloplasty on plasma
levels of atrial natriuretic factor, 33A
Can atrial natriuretic peptide secretion be
further stimulated in patients with
severe congestive heart failure?, 33A
Effect of atrial natriuretic peptide on
coronary blood flow and myocardial
performance, 242A
Effects of f3-adrenergic stimulation on atrial
natriuretic factor and plasma renin in
the dog, 242A
Expression of the genes encoding the fetal
isoforms of contractile proteins and
atrial natriuretic factor (ANF) in the
hypertrophied adult ventricles, lA
Hypertension post-cardiac transplantation: is
atrial natriuretic peptide deficiency a
factor in its development, 241A
Influence of orthotopic cardiac
transplantation on circulating atrial
natriuretic factor (ANF) in humans,
90A
Kinetics of endogenous atrial natriuretic
peptide release and metabolism in
humans, 119A
Plasma levels of atrial natriuretic factor in
acute myocardial infarction in man,
248A
Plasma levels of atrial natriuretic peptide in
congestive heart failure; correlation
with hemodynamic indices, 32A
Receptor stimulated acceleration of
phosphatidylinositol response enhances
atrial natriuretic polypeptide release in
isolated adult rat atrial myocytes, 134A
Role of atrial natriuretic factor in orthostatic
mediated sodium retention in
asymptomatic left ventricular
dysfunction, 117A
Ventricularoccurrence of ..atrial"
natriuretic factor: a marker for the
failing ventricle, lA
Atrial septal defect
Utility of color flow imaging for shunt
visualization in atrial septal defect, 3A
Atriopeptin 1II
Atriopeptin 1II induces early relaxation of
ventricle, 171 A
Atriotomy
Total atriotomy improves results of
transection of multiple accessory
pathways, IOOA
Atrioventricular block
Electrophysiological and pathological
assessmentof chronic first degree
atrioventricular block caused by closed-
chest catheter ablation with
radiofrequency energy in dogs, 95A
Atrioventricular canal defects
Repair of atrioventricular canal defects
utilizing Carpentier reconstructive
techniques, 205A
Atrioventricular junction
Catheter ablation of the atrioventricular
junction: analysis of failed allempts,
251A
Atrioventricular node
Phasic vagal discharge and AV nodal gap: a
new mechanism for an old
phenomenon, 253A
Transient inward current of the rabbit
atrioventricular node induced by low
K + concentration, 209A
Vagal effects in the AV node: an anatomic
and electrophysiologic correlation,
252A
Atrioventricular pathways
See Accessory atrioventricular pathways
Auscultation
Comparativeevaluation of Doppler
techniques and auscultation for
detection of mitral regurgitation (MR),
238A
Automaticity
Electro-thermal catheter modification of
atrioventricular nodal conductionand
automaticity in man, 252A
Negative chronotropic effects of hypoxia on
the automaticity in the rabbit sinus
node, 252A
Baroreflex sensitivity
Baroreflex sensitivity and sudden death in
conscious dogs before and after
myocardial infarction, 80A
Bernoulli equation
Can the modified Bernoulli equation be used
to accurately determine intraventricular
pressure throughout systole in patients
with valvular aortic stenosis'!, 236A
The simplified Bernoulli equation correctly
predicts outflow tract pressure gradients
in hypertrophic cardiomyopathy: an in
vitro study, 237A
Beta-adrenergic blockade
See also specific agents
Are calcium antagonists as effective as beta
blockers for the treatment of
thyrotoxicosis'?, 164A
Beta-blocker therapy for patients with
ventricular tachyarrhythmias and
impaired left ventricular function, 71A
Effects of titrating beta adrenergic blockade
dose on silent myocardial ischemia in
ambulatory patients, 68A
The interactionof exercise training and beta
blockade in patients with moderate
hypertension, 235A
Skeletal muscle and cardiovascularchanges
with training in hypertensives on and
off beta-adrenergic blockade, 56A
Use of exercise Doppler to evaluate cardiac
drugs: comparative influence of beta
and calcium blockers on aortic
acceleration velocity, 18A
Beta-adrenergic receptors
Adrenergic influences on the denervated
human coronary circulation, 149A
f3-Adrenergic receptor-G, interaction in
phospholipid vesicles, 133A
Characteristics and distribution of
sarcolemmal and intracellular f3-
receptors in normal human
myocardium, 134A
Effects of acute ischemia and reperfusion on
myocardial f3-adrenoreceptors and
adenylate cyclase activity, 80A
Left ventriculardiastolic function during
ventricular tachycardia: effects of f3-
adrenergic receptor activation on
myocardial relaxation, 202A
Quantitativeautoradiographic delineation of
f3-adrenergic receptors in human
ventricular myocardium, l33A
Selective alpha and beta adrenergic
regulation of pulmonary intravascular
volume, 170A
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Beta adrenergic stimulation
Effects of ,B-adrenergic stimulation on atrial
natriuretic factor and plasma renin in
the dog. 242A
Hypokalemia by ,B-adrenergic stimulation in
the coronary circulation of the dog.
92A
Bland- White-Garland Syndrome
Post operative evaluation after end-to-end
subclavian left coronary anastomosis in
Bland-White-Garland syndrome. 205A
Blood flow
Adrenergic influences on the denervated
human coronary circulation. 149A
Analysis of blood flow velocity and
thrombogenesis in left atrial appendage
by transesophageal two dimensional
echocardiography, 212A
Aortic pressure and diameter identify
mechanism of blood flow during CPR.
200A
Blood velocity measurementduring selective
coronary angiography before and after
percutaneous transluminal coronary
angioplasty, 70A
Central venous flow velocity patterns can
differentiate constrictive pericarditis
from restrictive cardiomyopathy. 119A
Doppler echocardiography in cardiac
tamponade: exaggerated respiratory
variation in transvalvular flow velocity
integrals. 17A
Comparison of Doppler and nuclear
magnetic resonance imaging for
measurement of volume flow. 19A
Digital angiographic determination of
absolute coronary blood flow. 161A
Effect of atrial natriuretic peptide on
coronary flow and myocardial
performance. 242A
Effect of graded reductions in regional
myocardial blood flow in regional
diastolic left ventricular wall dynamics.
218A
Experimental validation of echo-Doppler
measurement of volume flow proximal
to the stenotic aortic valve. 235A
Influence of sampling site upon the ratio of
atrial to early diastolic transmitral flow
velocities by Doppler. l6A
Left ventricular function and blood flow
during exercise in a canine model of
chronic cyanosis. 35A
Maximum coronary blood flow beyond a
coronary artery stenosis is reduced by
an acute increase in left ventricular
afterload, 254A
Measurement of absolute coronary blood
flow using a standard angioplasty
catheter. 69A
Measurement of regional myocardial blood
flow in-vivo using myocardial contrast
2D echocardiography. 2A
The mechanics of coronary garden-hose in
intact and isovolumic swine hearts ,
169A
A quantitative model for transmitral blood
flow: description with in vitro
verification, 212A
Spatial and temporal heterogeneity of
coronary blood flow by myocardial
contrast echocardiography. 112A
Spatially localized flow measurement by
nuclear magnetic resonance imaging,
46A
Total and regional myocardial blood flow in
chronic experimental mitral
regurgitation. l69A
Blood pressure
See also Hypertension
Failure of exercise blood pressure
parameters 10 predict left ventricular
mass.5lA
Genetic effects of left ventricular mass on
blood pressure in children. 52A
How useful is diastolic blood pressure:
insights from Framingham Study. 114A
Influence of 30 year mean blood pressure
levels on left ventricular mass: the
Framingham Study. 115A
Sex hormones and blood pressure levels in
white and black children: the Bogalusa
Heart Study. 55A
Body weight
The importance of body weight as a
determinant of cardiac structure and
function in adolescents. 52A
Bretylium
Antitibrillatory effects of high-dose
bretylium and a lidocaine-bretyl iurn
combination during cardiac arrest and
cardiopulmonary resuscitation. 228A
Bundle branch block
False-positive TL-20I defects in left bundle
branch block: relationship to left
ventricular dilatation. 139A
Identification by frequency-domain analysis
of patients with bundle branch block al
risk for sustained ventricular
tachycardia. 207A
The signal averaged electrocardiogram in
patients with ventricular tachycardia
and bundle branch block. 208A
Calcium
Abnormal action potentials and calcium
handling in myopathic human
myocardium. I72A
Decreased calcium uptake by cardiac
sarcoplasmic reticulum in human
cardiomyopathy . 148A
Effects of blood ionized calcium on
myocardial mechanics in humans. 6A
Increased intracellular CA + + may be
important also for early
afterdepolarization. 210A
Ionic defibrillation of calcium overloaded
heart , 127A
Calcium antagonists
See also specific agents
Are calcium antagonists as effective as beta
blockers for the treatment of
thyrotoxicosi s". I64A
Calcium entry blockers and alpha-mediated
vasoconstriction: effect of verapamil
and nicardipine in human forearm,
164A
Effect of acute or chronic administration of
calcium antagonists on mortality
following myocardial infarction. 24A
Myocardial protection by calcium channel
blockers during ischemia and
reperfusion. 146A
Use of exercise Doppler to evaluate cardiac
drugs: comparative influence of beta
and calcium blockers on aortic
acceleration and velocity. 18A
Calcium ATPase
Mechanisms of experimental ventricular
pacing-induced heart failure: role of
myocardial norepinephrine and
sarcoplasmic reticulum calcium
ATPase. I7IA
Calcium channel proteins
Isolation and characterizationof cardiac
Ca+ + channel protein, 156A
Captopril
The acute hemodynamic effects of
intravenous captopril and intravenous
digoxin in patients with heart failure.
102A
Captopril in mild to moderate heart failure
over 18 months: effects on morbidity
and mortality, 42A
Comparison of effects of captopril and
digoxin on ejection fraction. exercise
tolerance. clinical status and
arrhythmias in patients with mild to
moderate heart failure. 203A
Fast and safe blood pressure reduction from
sublingual captopril, 226A
A randomized comparison of hydralazine
and captopril in the treatment of severe
cardiac failure. 103A
Skeletal muscle perfusion in CCF: the
effects of captopril, 202A
Cardiac amyloidosis
Senile cardiac amyloidosis with functional
impairment: diagnosis by myocardial
biopsy and immunochemistry . 154A
Cardiac arrest
Effect of coronary bypass surgery on
survival of patients with resuscitated
cardiac arrest: a CASS Registry study.
148A
Cardiac catheterization
Acute complications of therapeutic catheter
procedures in congenital heart disease.
76A
Incremental value of clinical examination.
echocardiography and cardiac
catheterization in the evaluation of
aortic valve disease. 20A
Muhivariable analysis of hospital mortality
in acute myocardial infarction patients
undergoing interventional
catheterization. 233A
Cardiac conduction
See Conduction
Cardiac output
Effects of increases in heart rate on left
ventricular volume and cardiac output
in the human fetus. 34A
Precise measurement of contrast clearance
cardiac output using cine computed
tomography. 161A
Cardiac tamponade
Doppler echocardiography in cardiac
tamponade: exaggerated respiratory
variation in transvalvular flow velocity
integrals. 17A
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Superior vena cava flow velocity patterns
can diagnose cardiac tamponade in
patients with pericardial effusions.
118A
Cardiac transplantation
See Cl/SO Grafts: Allografts
Accelerated coronary vascular disease in the
heart Iransplant patient: coronary
arteriographic find ings. 149A
Ambulatory inotropic therapy as a bridge to
cardiac transplantation. 89A
Effect of ischemic time to the transplanted
human heart on the subsequent left
ventricular function. 29A
Effects of antihistamines on sinus node
function and atrioventricular conduction
in response to rapid atrial pacing in
cardiac transplant patients. 96A
Eosinophilic myocarditis in heart transplant
recipient hearts. 144A
An evaluation of the cardiovascular
responses to dynamic exercise after
combined heart and lung
transplantation. 57A
Frequency analysis of the surface-ECG for
recognition of acute rejection after
orthotopic heart transplantation in man.
30A
Influence of orthotopic cardiac
transplantation on circulatory atrial
natriuretic factor (ANF) in humans.
90A
The influence of pretransplant hemodynamic
status on operative mortality. 29A
Influence of recurrent rejection episodes on
left ventricular function on the
transplanted heart. 221A
Intravenous cyclosporine
immunosuppression for cardiac
transplantation. 135A
Involvement of norepinephrine kinetics one
year post orthotopic cardiac
transplantation and normalization of
response to orthostatic stress. 221A
Long-term exercise training and cardiac
output following cardiac
transplantation. 235A
OKT3 monoclonal antibody for early
prophylaxis in cardiac transplantation.
30A
A quantitative assessment of the quality of
life after combined heart-lung
transplantation. 30A
Reflex responses to lower body negative
pressure are markedly impaired in heart
failure patients before and after cardiac
transplantation. 147A
Retransplantation for severe accelerated
coronary vascular disease in heart
transplant. 29A
Risk factors of right heart failure (RHF)
after orthotopic heart transplantation
(HTX).90A
Systolic and diastolic ventricular
performance during supine exercise
following heart transplantation, 57A
Cardiogenic shock
The effecl of coronary reperfusion on the
survival of patients with cardiogenic
shock due to acute myocardial
infarction. 233A
Cardiomyopathy
See Cl/SO Hypertrophic cardiomyopathy
Abnormal action potentials and calcium
handling in myopathic human
myocardium. I72A
Apparently idiopathic sustained ventricular
tachycardia response 10 metoprolil in
young patients. Histologic evidence of
silent cardiomyopathy. I02A
Cardiovascular reserve in idiopathic dilated
cardiomyopathy: influence of right
ventricular function. 41A
Central venous flow velocity patterns can
differentiate constrictive pericarditis
from restrictive cardiomyopathy. 11 9A
Constrictive pericarditis and restrictive
cardiomyopathy. differentiation by
Doppler recording of atrioventricular
flow velocities. 17A
Decreased calcium uptake by cardiac
sarcoplasmic reticulum in human
cardiomyopathy. 148A
Efficacy of prednisone therapy for new onset
idiopathic dilated cardiomyopathy.
143A
Enzymatic monitoring in dilated
cardiomyopathy: evidence for cardiac
platelet accumulation. I44A
Oral MDLl7043 in severe cardiomyopathy.
163A
Relation between left and right ventricular
function and norepinephrine in plasma
and myocardium in patients with
primary dilated cardiomyopathy. 116A
Right vs left ventricular biopsy in dilated
cardiomyopathy. 116A
Selective coronary vasodilator effect of
enalaprilat in patients with dilated
cardiomyopathy: demonstration by a
bilateral intracoronary infusion
technique. 192A
Value of electrophysiologic study in patients
with idiopathic dilated cardiomyopathy
and sustained ventricular tachycardia,
I07A
Cardioplegia
Atrial activity during cardioplegia and
postoperative arrhythmias, 7A
Heart block associated with high magnesium
cardioplegia. 7A
Improved distribution of cardioplegia with
pressure controlled intermittent
coronary sinus occlusion (PISCOJ, 88A
Ventricular dysfunction following
hypothermic crystalloid cardioplegia.
improvement by antiplatelet therapy.
89A
Cardiopulmonary resuscitation
Analysis of mitral valve motion and
transmural flow in dogs during manual
cardiopulmonary resuscitation. 200A
Aortic pressure and diameter identify
mechanism of blood flow during CPR.
200A
Differences in arterial. venous and
myocardial blood acid-base status
during cardiopulmonary resuscitation.
20 lA
High impulse cardiopulmonary resuscitation
improves 24 hour survival in a canine
model of cardiac arrest. 200A
Cardiovascular reflexes
Postural cardiovascular reflexes involve
forearm but not calf resistance vessels.
170A
Cardio vascular reserve
Cardiovascular reserve in idiopathic dilated
cardiomyopathy: influence of right
ventricular function. 41A
Cardioversion
See a/so Defibrillation
Potential risk of low energy cardioversion
attempts by implantable defibrillators,
168A
Prospective evaluation of ventricular pacing
and high energy transvenous shocks
using a triple electrode array for '
cardioversion of ventricular
tachycardia. 141 A
Carnitine
The cardiac manifestations in disorders of
fatty acid and carnitine metabolism.
35A
Catheters
See a/so Cardiac catheterization
Assessment of coronary flow reserve (CFR)
during angioplasty using a Doppler tip
balloon catheter: comparison with
digital subtraction cineangiography.
197A
The autoperfusion balloon angioplasty
catheter prevents ischemia during
prolonged balloon inflation. I06A
Catheter ablation at the anulus using
radiofrequency current in canines. 99A
Catheter ablation of the atrioventricular
junction: analysis of failed attempts.
25lA
Catheter ablation using radiofrequency
energy: control of lesion volume and
shape by varying power and duration of
ablation. 128A
Catheter mediatedelectrical ablation of
posterior septal accessory pathways:
complications and effectiveness. 250A
Comparison of the techniques for recording
atrial electrograms obtained using
Swan-Ganz catheter. 222A
Criteria for induction of chronic complete
heart block by His bundle fulguration,
251A
Efficacy of coronary artery perfusion
catheters in patients with failed
angioplasty and acute myocardial
ischemia. I05A
Electrogram patterns predicting successful
catheter ablation of ventricular
tachycardia. 152A
Electro-thermal catheter modification of
atrioventricular nodal conduction and
automaticity in man. 252A
Experience with catheter ablation of
accessory pathways. 251A
Impedance changes during catheter ablation
by radiofrequency energy: a potential
method for monitoring efficacy of
lesion generation. 95A
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Measurement of absolute coronary blood
flow using a standard angioplasty
catheter, 69A
Non-surgical percutaneous endarterectomy
using a mechanical rotational catheter
in normal coronary arteries in vivo.
188A
The perfusion balloon catheter: a new
method for safe prolongedcoronary
dilatation, I06A
A prototype catalytic thermal tip catheter:
design parametersand in vitro tissue
studies, 187A
Radiofrequency catheter ablation in the
coronary sinus, 99A
Results of transcatheterablation of
ventricular tachycardia in 33 patients,
250A
Selective catheter ablation of canine
ventricular myocardium with
radiofrequency current, 99A
Spontaneous heart rate and Cardiac function
after atrioventricularjunctional
ablation, 251A
Transcatheter electrical ablation of accessory
pathways in children, 36A
Transvenous ablation of the atrioventricular
junction in humans with high-frequency
energy,99A
Catheterization
See Cardiac catheterization
Celiprolol
A comparison of celiprolol to propranolol in
angina pectoris: results of an
international double-blind study, 192A
Cerebrovascular disease
Extent of coronary disease in patients with
cerebrovascular and peripheral vascular
disease. 77A
Chest pain
Etiology of chest pain in patients with mitral
valve prolapse, 9A
Nuclear ejection fraction and Doppler
ejection profilescorrelate during
exercise in patients with chest pain,
18A
Cholesterol
Are serum triglyceride levels a determinant
of tracking of high density lipoprotein
cholesterol? The Bogalusa Heart Study,
54A
Changes in apolipoprotein and HDL
subtraction levels following partial ileal
bypass: POSCH 5-year results, 54A
Cholesterol screening in patients undergoing
coronary bypass surgery, 79A
High density-lipoprotein cholesterol and
apolipoprotein A-I levels in children:
interrelationship and correlates in the
Bogalusa Heart Study. 55A
Negative bias and variability in reflotron
capillary cholesterol determinations,
54A
Physician recognition of coronary risk
factors: a disparity between approach to
hypertension and hypercholesterolemia
in patients hospitalized on a medicine
service. 79A
Post myocardial infarction cholesterol
management by primary physicians,
77A
Cigarette smoking
See Smoking
Cine computed tomography
Determination of myocardial risk area
following coronary occlusion with Cine
computed tomography, 158A
Heterogeneity of diastolic filling in normal
patients as assessed by cine computed
tomography, l59A
Precise measurement of contrast clearance
curve cardiac output using cine
computed tomography. 161 A
Regional myocardial flow reserve in normal
patients using cine computed
tomography, 160A
Validation of regional myocardial perfusion
by cine-CT, l60A
Cinevideodensitometry
Comparison of cinevideodensitometric and
caliper measurement of coronary
stenosis after angioplasty, 196A
Coarctation of the aorta
Balloonangioplasty for native coarctations
of the aorta: long-term results. l29A
Balloon dilatation angioplasty for unoperated
coarctation of the aorta in children: 2
year follow-up and late sequelae, 132A
Intermediate followup of balloon dilatation
angioplasty of native coarctation, 75A
Intraoperative balloon angioplasty of aortic
coarctation, 131A
Long-term results of percutaneous balloon
angioplasty (PBA) for native
coarctation, 75A
Residual gradients following aortic
coarctation repair adversely affect
survival after subsequent repair of
ventricular septal defect, 205A
Substantial improvement in noninvasive
diagnosis of coarctation and
differentiation from patent ductus:
Doppler evaluation of descending aortic
waveforms patterns. 3A
Cocaine
Coronary artery spasm in patients with
cocaine induced acute myocardial
infarction, 172A
Myocardial infarction associated with
cocaine use, 25A
Cod liver oil
See Fish oil
Coenzyme QIO
Reduction of reperfusion injury by rapid
acting coenzyme QIO administered
intravenously just prior to reperfusion,
93A
Collateral vessels
Coronary collaterals preserve left ventricular
function: evidence in patients
undergoing coronary angioplasty, 158A
Determinants of collateral reserve: can
baseline clinical or angiographic
variables predict the degree of collateral
filling observed immediately after
sudden coronary occlusion. 196A
Recruitable collateral predicted by lesion
severity, 182A
Color Doppler flow imaging
See also Mapping
Analysis of color Doppler: an in vitro study
of the effects of jet velocity on Doppler
color flow mapping, IIOA
Areas of jets by color flow Doppler vary
with orifice size, IIOA
Color Doppler assessment of aortic valve
stenosis, 65A
Color Doppler flow mapping of pulmonary
artery flow in an animal model of
patent ductus arteriosus, 3A
Color flow Doppler study of the effects of
afterload on the spatial distribution of
mitral regurgitant jets, 67A
Complementary role of magnetic resonance
imaging and real-time Doppler color
flow mapping for post-op evaluation
after surgery for tetralogy of Fallot,
165A
The curvilinear relation between aortic
regurgitant fraction and color flow jets:
intraoperative 2-dimensional Doppler
and electromagnetic flowmeter
correlation, 66A
Determinants of spatial resolution of color
Doppler flow mapping systems: in vitro
investigation, III A
Does the spatial orientationof jets on color
Doppler studies permit accurate angle
correction of CW velocities? 65A
Elucidation of the natural history of
ventricular septal defects by serial color
Doppler flow mapping studies, 165A
Estimation of pulmonary artery pressure in
children with ventricular septal defect:
real-time color flow/continuous wave
Doppler application, l28A
Feasibility analysis of 3-dimensional
reconstruction of color Doppler flow
velocities. 214A
Hemodynamic implications of jet size by
color Doppler flow imaging in patients
with mitral regurgitation, 67A
Lessons provided by color flow imaging:
disturbed flow jets tend to adhere to
adjacent walls, 3A
Merging color Doppler imaging with 4
dimensional echocardiogram
reconstruction, IliA
Noninvasive analysis of left ventricular
blood-flow dynamics in left ventricular
aneurysm by color flow mapping, 66A
The physiology of mitral regurgitation:
vortex formation in the left atrium, 67A
Quantification of aortic insufficiency using
color Doppler flow imaging, 66A
Quantification of jet energy by computer
analysis of color Doppler images, 65A
Quantitative assessment of aortic
insufficiency by color Doppler, 66A
Regurgitant volumes by color flow
overestimate injected volumes in an in
vitro model, I IOA
The shape of regurgitant jets: in vitro flow
visualization and color flow Doppler
studies, I lOA
Transesophageal Doppler color flow
imaging: initial experience, 212A
Utility of color flow imaging for shunt
visualization in atrial septal defect, 3A
Variability of color flow mapping Doppler
imaging of regurgitant jets in an animal
model of mitral insufficiency, 64A
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Verification of velocity assignment by color
Doppler flow mapping: development of
a computer method for angle correction
of color Doppler velocities. 65A
Complement activation
Complement activation after protamine
administration following coronary
angiography. 180A
Computed tomography
See Cine computed tomography;
Tomography. computed
Conduction
Conduction through an isthmus of tissue in
vivo. 154A
Correlation of abrupt changes in
refractoriness and functional conduction
block by high resolution electrode
recordings in the post infarcted canine
heart. 91A
Effect of antihistamines on sinus node
function and atrioventricular conduction
in response to rapid atrial pacing in
cardiac transplant patients. 96A
The effect of AV simultaneous pacing on
the retrograde Kent bundle conduction
in patients with concealed WPW
syndrome. 12A
Electro-thermal catheter modification of
atrioventricular nodal conduction and
automaticity in man. 252A
Congenital heart disease
See also specific diseases
Acute complications of therapeutic catheter
procedures in congenital heart disease,
76A
Double balloon technique for dilatation of
valvular or vessel stenosis in congenital
and acquired heart disease, 76A
Fast dynamic MRI studies of flow in
congenital heart disease: initial
experience. l60A
Oximetry during exercise in children with
cyanotic congenital heart disease. 59A
Congestive heart failure
Abnormal skeletal muscle metabolism in
heart failure: lack of relation to flow.
58A
The acute hemodynamic effects of
intravenous captopril and intravenous
digoxin in patients with heart failure.
102A
Acute hemodynamic effects of a new
intravenous inotropic agent, dibutryf
cyclic AMP on patients with congestive
heart failure-a comparison with
dobutamine, 162D
Atrial natriuretic peptide in experimental
heart failure: atrial content. plasma
levels and effects of volume loading.
11 9A
Atrial natriuretic peptide produces favorable
hemodynamic changes and increases
sodium excretion in congestive heart
failure (CHFl. 11 9A
Can atrial natriuretic peptide secretion be
further stimulated in patients with
severe congestive heart failure", 33A
Captopril in mild to moderate heart failure
over 18 months: effects on morbidity
and mortality. 42A
Chronic edematous heart failure does not
impair skeletal muscle vasodilatory
capacity in the dog, I44A
Does digoxin enhance exercise left
ventricular function in patients with
congestive heart failure", 132A
DPI 20 1-106. a new inotropic agent:
hemodynamic improvement in patients
with congestive heart failure. 162A
Effect of dobutarnine infusion on serum
electrolytes and arterial oxygenation in
congestive heart failure, 34A
Effect of an " inotropic" placebo on the
exercise capacity of severe congestive
heart failure patients. 60A
Effects of heart rate on hydraulic work in
heart failure. 43A
Enalapril in the chronic treatment of
congestive heart failure. 203A
Epidemiology and prevention of cardiac
failure: Framingham Study insights,
76A
Failure of intravenous amrinone to improve
renal hemodynamics and neruohumoral
status in patients with severe chronic
heart failure, 103A
Functional capacity for prognosis of survival
in mild to moderate heart failure. 59A
Importance of 2,3-diphosphoglyceric acid to
oxygen transport in congestive heart
failure. l86A
Interdependence of ventricular wall stress
and ejection fraction in determining
survival in severe chronic heart
syndrome. 202A
Mechanisms of experimental ventricular
pacing-induced heart failure: role of
myocardial norepinephrine and
sarcoplasmic reticulum calcium
ATPase, 171 A
Persistent hemodynamic effects of lisinopril
after chronic therapy in congestive
heart failure. I04A
Plasma levels of atrial natriuretic peptides in
congestive heart failure: correlation
with hemodynamic indices, 32A
Potentiation of vasodilator response to
mental stress in severe heart failure.
42A
Prognostic value of echocardiographic
parameters in chronic congestive heart
failure: the VHEFT Study. 202A
A randomized comparison of hydralazine
and captopril in the treatment of severe
cardiac failure, I03A
Skeletal muscle perfusion in CCF: the
effects of captopril, 202A
Which patients with congestive heart failure
have malignant ventricular
tachyarrhythmias? Potential metabolic-
hormonal interactions in high-risk
SUbsets. 33A
Contractile function
Atrial natriuretic factor has no direct effect
on myocardial contractility, 170A
Non-invasive assessment of the end-systolic
stress-length and stress shortening
relation in hypertrophic
cardiomyopathy. 20IA
Contractile proteins
Expression of the genes encoding the fetal
isoforms of contractile proteins and
atrial natriuretic factor (ANF) in the
hypertrophied adult ventricles, IA
Coronary artery disease
See also Angina pectoris; Angiography;
Angioplasty. coronary; Atherosclerosis;
Revascularization Coronary artery
disease after chest irradiation, l76A
Digital two-dimensional echocardiographic
evaluation of the proximal left anterior
descending coronary artery. 157A
Impaired left ventricular diastolic filling in
patients with coronary artery disease
and normal systolic function:
correlation for age effect, 6A
Does noninvasive testing predict 3-vessel or
left main disease in patients with
coronary artery disease and left
ventricular dysfunction. 67A
Long-term follow-up of angiographically
documented coronary artery disease in
patients under thirty, 151 A
Modulation of coronary constriction by
myocardial ischemia. 186A
Progression of native coronary artery disease
5 and 10 years after medical versus
surgical therapy for angina, 175A
The ratio of apoprotein B to apoprotein A-I
as the best predictor of premature
coronary artery disease in women. 54A
Reactivity to mental stressors in
asymptomatic patients with coronary
disease and silent myocardial ischemia,
175A
Relationship between left ventricular systolic
asynchrony and filling in patients with
coronary artery disease, 6A
Retransplantation of severe accelerated
coronary vascular disease in heart
transplant, 39A
Safety of carotid endarterectomy under
regional anesthesia in patients with
coronary artery disease, 23A
Scintigraphic progression of coronary artery
disease after single vessel acute
myocardial infarction, l39A
Coronary artery spasm
Coronary artery spasm in patients with
cocaine induced acute myocardial
infarction. 172A
Does coronary spasm explain false positive
responses during exercise test" , 122A
Coronary endoprosthesis
First follow-up data on the transluminally
implanted coronary endoprosthesis,
I06A
Percutaneously implantable endo-coronary
prosthesis: preliminary results in the
treatment of post-dilatation re-stenosis.
I06A
Coronary blood flow
See Blood flow
Coronary flow reserve
Abnormalities of coronary flow reserve and
esophageal motility in syndrome X: a
systemic disorder of smooth muscle
reactivity, 249A
Assessment of coronary flow reserve (CFR)
during angioplasty using a Doppler tip
balloon catheter. Comparison with
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digital subtraction cineangiography.
197A
Assessment of relative coronary flow reserve
with dynamic positron emission
tomography and H1 150 . I60A
Correlation of digital angiography with
Doppler estimation of coronary flow
reserve. 161 A
Digital angiographic transfer function
analysis of myocardial flow and
coronary reserve: comparison with
conventional time-density parameters.
44A
Digital subtraction angiography flow reserve
imaging-validation of a flow model
and volume parameters. MA
Hyperthyroid pig: abnormal exercise
responses associated with reduced
coronary reserve. 59A
The impact of blood fluidity on coronary
reserve in patients with hypertensive
heart disease. 53A
Quantitative assessment of coronary reserve
in critical stenosis by sonicated contrast
echocardiography: comparison with
microspheres and Doppler flow probe.
11 2A
Reduction of ventricular function correlated
with impairment of coronary flow
reserve but not endomyocardial biopsy
following cardiac transplantation. l l6A
Regional myocardial flow reserve in normal
patients using cine computed
tomography. 160A
Coronary occlusion
See also Reocclusion
Can recruitable collaterals protect global left
ventricular function after abrupt
coronary occlusion", 149A
Compensatory augmentation of normal
regional function following coronary
occlusion: relation to myocardial area at
risk and extent of ischemic dysfunction.
92A
Determination of myocardial risk area
following coronary occlusion with cine
computed tomography. 158A
Improved distribution of cardioplegia with
pressure controlled intermittent
coronary sinus occlusion (PISCO). 8RA
Prolonged post-ischemic dysfunction after
repetitive brief coronary occlusions
interspersed with reperfusions through a
critical stenosis. 188A
Quantitative angiographic morphology of the
coronary artery lesions at risk for
thrombotic occlusion. 238A
T l and T2 changes with severe flow
reduction at 24 and 72 hours after
coronary occlusion in dogs, 74A
The accuracy of coronary lumen quantitation
by rapid. on-line digital angiographic
methods, MA
Coronary revascularization
Set! Revascularization
Coronary stenosis
See also Angioplasty, coronary; Restenosis
Accuracy of angiography in subclassifying
critical coronary arterial stenosis:
implications for balloon angioplasty,
179A
Accuracy of coronary stenosis quantitation
by digital subtraction coronary
angiography: an in vivo dog model.
45A
Comparison of cinevideodensitometric and
caliper measurements of coronary
stenosis after angioplasty, 196A
Comparison of positron tomography and
quantitative angiography in stenosis
analysis after acute thrombolysis and
angioplasty in evolving myocardial
infarction. 179A
Evidence that coronary stenosis alters left
ventricular end-systolic pressure-wall
thickness relations at rest even when
resting coronary blood flow is normal.
Experimental echocardiographic
studies. 219A
Prolonged post-ischemic dysfunction after
repetitive brief coronary occlusions
interspersed with reperfusions through a
critical stenosis. 188A
Coronary wedge pressure
Coronary wedge pressure: a predictor of
restenosis after angioplasty. 184A
Creatine kinase
Electrocardiographic and enzyrnatic findings
in non-Q wave infarction: results of the
multicenter prospective randomized
diltiazern reinfarction study. 224A
Importance of collateral perfusion in kinetics
of creatine kinase release. l74A
Rapid. quantitative assay of isoforrns in the
MM isoenzyme of creatine kinase in
plasma. 173A
Cr yosurgery
Discrete cryosurgical ablation of
atrioventricular node reentry
tachycardia in patients. 249A
Cyanosis
Left ventricular function and blood flow
during exercise in a canine model of
chronic cyanosis. 35A
Defibrillation
Decreased defibrillation thresholds with
large contoured patch electrodes in
dogs, 143A
Improved low energy defibrillation efficacy
in man using a biphasic truncated
exponential waveform. 142A
Ionic defibrillation of the calcium
overloaded heart. 127A
Lowering of cardiac defibrillation threshold
by aminophylline in the conscious dog.
142A
Mechanism of failure of subthreshold
defibrillation shocks. 94A
Modulation of lidocaine effects on
ventricular defibrillation, 166A
Procainamide does not affect ventricular
defibrillation in dogs. l66A
Relationship between resetting and
termination of sustained ventricular
tachycardia: implications for
antitachycardia pacing. 167A
Sequential pulse defibrillation in man:
comparisons of orthogonal sequential
pulse using 4 patches to single pulse
defibrillation using 2 patches, 167A
Sequential pulse defibrillation thresholds in
man: effect of pulse width variation.
166A
Ventricular fibrillation amplitude predicts
ability to defibrillate. 152A
Ventricular fibrillation duration affects
defibrillation, l42A
Defibrillator
Antitachycardia pacemaker and automatic
implantable cardioverter defibrillator as
sole therapy for ventricular tachycardia,
140A
Automatic irnplantable cardioverter
defibrillator: problems and
complications. l42A
Clinical outcome of patients with ventricular
tachyarrhythmias treated with automatic
implantable defibrillator without
concomitant drug therapy, l68A
Does an AID generator need replacement
when the battery is depleted? 168A
Exercise testing in patients with automatic
implantable cardioverter defibrillators,
169A
Five year experience with the automatic
implantable defibrillator, l67A
The implanted defibrillator: defibrillation
threshold stability over lime, 168A
Long-term efficacy and complications of
antitachycardia pacemakers compared
with implantable defibrillators, 143A
Potential risk of low energy cardioversion
attempts by implantable defibrillators,
168A
Deoxyglycose
Augmented uptake of 2-C14D deoxyglycose
(2·DG) in reversibly-injured
myocardium. 93A
Desethylamiodarone
Anti-arrhythmic effects of
desethylamiodarone and amiodarone
against reperfusion-induced arrhythmias
in the anesthetized rat. 51A
A comparison of the acute
electrophysiologic effects of
amiodarone and desethylarniodarone,
50A
Diabetes
Altered fetal circulation in diabetic
pregnancies, 34A
Diabetes mellitus and hyperglycemia as risk
factors for cardiovascular disease:
influence of age and sex, The
Framingham Study, 55A
Dipyridamole-thallium predicts
complications in diabetics undergoing
peripheral vascular surgery. 69A
Influence of diabetes mellitus on the
hemodynarnic and clinical responses to
converting-enzyme inhibition in severe
chronic heart failure, 120A
Diagnostic teaching
Teaching cardiovascular physical diagnosis
in technologic era: requiem or reveille,
222A
Diastole
See also Ventricular filling; Ventricular
function
Heterogeneity of diastolic filling in normal
patients as assessed by cine computed
tomography. 159A
The importance of diastolic dysfunction in
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the development of clinically significant
adriamycin cardiotoxicity, 42A
Relations between global diastolic function
and exercise tolerance in ischemic left
ventriculardysfunction, 58A
Dibutryl cyclic adenosine monophosphate
Acute effect of dibutryl cyclic adenosine
monophosphate on coronary circulation
and cardiac energetics in patients with
heart failure, 162A
Acute hemodynamic effects of a new
intravenous inotropic agent, dibutyryl
cyclic AMP on patients with congestive
heart failure-a comparison with
dobutamine, l62A
Digitalis glycoside
See Glycosides
Digoxin
The acute hemodynamic effects of
intravenous captopril and intravenous
digoxin in patients with heart failure,
I02A
Comparison of effects of captopril and
digoxin on ejection fraction, exercise
tolerance, clinical status and
arrhythmias in patients with mild to
moderate heart failure, 203A
Decreased toxicity with a new semisynthetic
glycoside: comparison with digoxin,
133A
Does digoxin enhance exercise left
ventricular function in patients with
congestive heart failure?, l32A
Diltiazem
Are calcium antagonists as effective as beta
blockers for the treatment of
thyrotoxicosis?, (64A
Effects of diltiazem, nifedipine. and their
combination on transient ST-segment
deviations on the ambulatory ECG in
patients with stable angina, 177A
Effects of diltiazem on ventricular function
in non-Q wave infarction: results of the
multicenter randomized diltiazem
reinfarction study, I64A
High-dose intravenousdiltiazem in man.
Hemodynamic and antiischemiceffects
in impaired vs normal LV function,
I77A
Post-exercise ventricular arrhythmias
reduced by the calcium-entry blocker,
diltiazem, 228A
2,3 Diphosphoglyceric acid
Importance of 2,3-diphosphoglyceric acid to
oxygen transport in congestive heart
failure, 186A
Dipyridamole
See also Thallium-201
Comparison of exercise 2-dimensional
echocardiography and high dose
dipyridamole-echocardiography test for
diagnosis of coronary artery disease,
215A
Dipyridamole-thallium predicts
complications in diabetics undergoing
peripheral vascular surgery, 69A
Effect of maintenance oral theophylline
therapy on dipyridamole thallium
myocardial imaging using SPECT and
dipyridamole-induced hemodynamic
changes, 139A
High dose dipyridamole-echocardiography
test in patients with syndrome X, 221A
Nuclear magnetic resonance imagingof
myocardial ischemiaduring
dipyridamole effect in a partial
coronary artery stenosis model. 74A
Quantitativeanalysis of dipyridamole
thallium images for the detection of
coronary artery disease, 25A
Regional myocardial flow reserve in normal
patients using cine computed
tomography. I60A
The significance of induced " cardiac" pain
during dipyridamole scintigraphy, 121 A
Diuretics
Diuretic use: a risk factor for mortality after
aortic valve replacement, 21A
DNA
Effect of adriamycinon heart mitochondrial
DNA synthesis, 38A
Dobutamine
Acute hemodynamic effects of a new
intravenous inotropic agent, dibutryl
cyclic AMP on patients with congestive
heart failure-a comparison with
dobutamine, 162A
Dobutamine: an altemative post infarction
stressor to exercise testing, 121 A
Effect of dobutamine infusion on serum
electrolyte and arterial oxygenation in
congestive heart failure, 34A
The effects of chronic dobutamine treatment
on the normotensive and hypertensive
heart, 37A
Doppler echocardiography
See also Color Doppler flow imaging;
Echocardiography; Exercise testing;
Accuracy of Doppler in predictingseverity
of aortic stenosis: a practical
applicationof the continuity equation,
2lA
Assessment of tricuspid stenosis by Doppler
echocardiography, 237A
Cardiac Doppler flows during fetal
dysrhythmias: studies of post
extrasystolic potentiation and recovery
from tachycardia, 35A
Comparativeevaluation of Doppler
techniques and auscultation for
detection of mitral regurgitation (MR),
238A
Comparison of Doppler and nuclear
magnetic resonance imaging for
measurement of volume flow, 19A
Comparisonof two Doppler methods for
evaluating aortic regurgitation, 238A
Correlation of digital angiographic with
Doppler estimation of coronary flow
reserve, 16lA
Detection and quantification of constriction
of the fetal ductus arteriosus by
Doppler echocardiography, 2A
Doppler echocardiography before, during
and after percutaneous aortic
valvuloplasty, 218A
Doppler echocardiographic study of left
ventriculardiastolic filling in ischemia:
effect of reprefusion on mitral flow
velocity,214A
Doppler echocardiography in cardiac
tamponade: exaggerated respiratory
variation in transvalvular blood flow
velocity integrals. 17A
Dopplerevaluation of left ventricular
diastolic filling function during
angioplasty . 213A
Doppler evaluation of left ventricular filling
dynamics during coronary angioplasty,
213A
Doppler evaluation of left ventricular inflow
during transient myocardial ischemia,
213A
Doppler indices of left ventriculardiastolic
function are dependent on filling
pressure in man, 198A
Early diastolic interaction between the aortic
regurgitant jet and mitral inflow. A
pulsed Doppler study, 83A
Estimationof valve area in patients with
aortic valve disease by Doppler
echocardiography and radionuclide
angiography, 236A
Evaluation of left ventriculardiastolic filling
during coronary angioplasty using
Doppler echocardiography, 213A
Evaluation of left ventriculardiastolic filling
in isolated aortic stenosis using Doppler
echocardiography , 17A
Experimental validation of echo-Doppler
measurement of volume flow proximal
to the stenotic aortic valve, 235A
Failure of the Doppler pressure halftime to
accuratelydemonstratechange in mitral
valve area following percutaneous
mitral valvotomy, 2l8A
Frequencyof unusually high transvalvular
Doppler velocities in patients with
normal prosthetic valves, 238A
Influence of aging on left ventricular
diastolic function as assessed by
Doppler echocardiography, l6A
Influence of sampling site upon the ratio of
atrial to early diastolic transmitral flow
velocities by Doppler, 16A
Mitral regurgitation after percutaneous mitral
valvotomy in adults: evaluation by
pulsed Doppler echocardiography,
2l7A
Non-invasive assessmentof left ventricular
performance based on initial ventricular
impulse measured by Doppler
echocardiography, 18A
Noninvasive quantitation of aortic
regurgitant area utilizing Doppler half-
time analysis, 237A
Noninvasive renal blood flow by pulsed
Doppler ultrasound in piglets-
validation of the technique, 2l5A
Prediction of severity of aortic stenosis by
simple Doppler velocity measurements:
correlation with CATH in 100 patients,
256A
Preoperative non-invasive carotid evaluation
of coronary artery bypass patients, 86A
Pressure recovery distal to stenosis: potential
cause of gradient ..overestimation" by
Doppler, 237A
Pulsed Doppler echocardiographic detection
of tricuspid insufficiency in children,
l30A
A quantitative model for transmitral blood
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flow: description with in vitro
verification.2 12A
Simplification of the Doppler continuity
equation for calculating aortic valve
area. 236A
Substantial improvement in noninvasivc
diagnosis of coarctation and
differentiation from patent ductus:
Doppler evaluation of descending aortic
waveform patterns. 3A
Transesophageal 2-dimensional echo-
Doppler visualization of left main
coronary arterial anatomy and flow.
l79A
Validation of Doppler echocardiographically
derived peak filling normalized to
stroke volume: a comparison with
radionuclide angiographic techniques.
16A
Doxorubicin
Chronic doxorubicin induced cardiotoxicity
in rabbits: increased catecholamine
responsiveness. shorter contraction and
action potential duration. 147A
DPI·201·106
DPI-201-I06. a new inotropic agent:
hemodynamic improvement in patients
with congestive heart failure. 162A
Hemodynamic effects of DPI, a novel
cardiotonic drug with negative
chronotropic action. 162A
Hemodynamic and electrocardiographic
effects of the fast channel activator.
DPI 201-1 06. 161A
Mechanisms of inotropic and lusitropic
action of DPI 201-106 in mammalian
myocardium. 132A
Echocardiography
See also Doppler echocardiography
Acoustic microscopy of normal and
myopathic human myocardium:
implications for ultrasonic tissue
characterization. 211A
Aid of echocardiography in balloon
valvuloplasty for aortic stenosis and
mitral stenosis. 217A
Analysis of blood flow velocity and
thrombogenesis in left atrial appendage
by transesophageal two-dimensional
echocardiography, 212A
Clinical identification of amyloid and
hypertrophic cardiomyopathy using
quantitative texture analysis of digital
echocardiographic data. 211A
Comparison of predictive value of admission
2-0 echocardiography and
hemodynamics in acute myocardial
infarction. 158A
Digital two-dimensional echocardiographic
evaluation of the proximal left anterior
descending coronary artery. 177A
Echocardiographic abnormalities associated
with autosomal dominant polycystic
kidney disease, 9A
An ellipsoidal shell subtraction model for
determining right ventricular volume.
2l4A
Law of constant heart volume in humans: a
noninvasive assessment via x-ray CT.
MRI and echo. 38A
Measurement of regional myocardial blood
flow in-vivo using myocardial contrast
2-0 echocardiography. 2A
Merging color Doppler imaging with 4
dimensional echocardiogram
reconstruction. I 1IA
Mitral valve prolapse: additional support for
the " normalcy" of displacement in the
apical 4-chamber view only. 9A
Prevalence of mitral valve prolapse by two-
dimensional echocardiography: a
population based study. 77A
Prognostic value of echocardiographic
parameters in chronic congestive heart
failure: the VHEFT study. 202A
Rapid ultrasound enhancement of reperfused
myocardium by fluorocarbon emulsion.
126A
Regional and transmural dependence of
cardiac cycle variability in ultrasonic
backscatter: effect of acute myocardial
ischemia. 211 A
Reconstruction of echocardiographic images
using filtered two-dimensional Fourier
transforms: a superior method for noise
reduction. 214A
Two-dimensional echocardiographic
imaging: in vitro comparison of
conventional and dynamically focused
anular array transducers. 215A
Validation of infarct sizing by
echocardiographic 3-D endoardial
surface mapping in human autopsy
hearts. 219A
Echocardiography, contrast
Assessment of myocardial perfusion by
contrast enhanced digital subtraction
echocardiography, I 12A
Contrast echocardiography during cardiac
catheterization to assess regional
myocardial perfusion in humans. 11 3A
Quantitative assessment of coronary reserve
in critical stenosis by sonicated contrast
echocardiography: comparison with
microspheres and Doppler free probe.
1l2A
Quantitative myocardial perfusion imaging
using contrast 2-dimensional
echocardiography. I 12A
Spatial and temporal heterogeneity of
coronary blood flow by myocardial
contrast echocardiography. 112A
Spontaneous reduction in myocardial
perfusion deficit by contrast
echocardiography during infarction.
219A
Successful transpulmonary contrast
echocardiography in monkeys. Ili A
Echocardiography, exercise
Can exercise two dimensional
echocardiography replace exercise
thallium imaging? 216A
Comparison of exercise 2-dimensional
echocardiography and high dose
dipyridamole-echocardiography test of
diagnosis of coronary artery disease.
215A
Comparison of peak and post exercise
echocardiographic imaging in
evaluation of coronary artery disease.
217A
Echocardiographic posterior left ventricular
dyskinesis seen in the upright position
in healthy volunteers, 216A
Exercise echocardiography detection of
ischemic heart disease in patients with
normal wall motion at rest, 216A
Exercise echocardiography in the evaluation
of coronary artery disease. 216A
Effusions
Predictive factors for developmentof
chronic effusions following modified
Fontan procedure--do they exist",
204A
Eicosapentaenoic acid
Effects of eicosapentaenoic acid (EPA)
administration on platelet and
neutrophil function. and eicosanoid
biosynthesis in CAD. 136A
Ejection fraction
Impact of distal coronary perfusionon
ejection fraction response to balloon
inflation during PTCA. 69A
Left ventricular ejection fraction: a predictor
of myocardial infarct size with anterior
but not inferior wall infarction, 175A
Nuclear ejection fraction and Doppler
ejection profiles correlate during
exercise in patients with chest pain.
18A
Prognostic value of left ventricular ejection
fraction in patients with and without
signs of left ventricular myocardial
infarction. 23A
Serial changes in left ventricularejection
fraction following acute myocardial
infarction. 234A
Elastin
Age-related changes of elastin lamellae in
the human thoracic aorta. 53A
Electrocardiography
See also Ambulatory electrocardiography;
Mapping; Q waves; QRS complex;
Signal averaging; ST segment
Accuracy in the automatic detection of
ventricular fibrillation, 206A
Bedside detection of silent ischemia using a
12·lead programmable ECG monitor:
value of a multi-lead system. 223A
Can hemopericarditis induce ECG injury
pattern", 11 8A
Comparison of the techniques for recording
atrial c1ectrograms obtained using
Swan-Ganz catheters. 222A
Correlation of the electrocardiogram and
segmental wall motion abnormalities
during coronary artery occlusion. 180A
Discrimination of ventricular tachycardia
electrograrns by syntactic methods. 98A
Double-spike electrograms in atrial flutter:
validation as a marker of local atrial
conduction delay. 153A
ECG criteria for ventricular and
supreventricular tachycardia in wide
complex tachycardias with left bundle
branch morphology. 206A
The effect of exercise on the atrial
electrogram in humans. 32A
Electrocardiographic effects of sympathetic
imbalance. 95A
Electrocardiographic and enzymatic findings
in non-Q wave infarction: results of the
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multicenter prospective randomized
diltiazem reinfarction study. 224A
Electrocardiographic infarct evolution is
accelerated by successful thrombolysis.
63A
Electrocardiographic left atrial abnormalities
indicate diastolic ventricular
dysfunction in obesity. ll3A
Evolution of late potentials during the first
10 days after acute myocardial
infarction. 224A
Frequency analysis of the surface-ECG for
recognition of acute rejection after
orthoptic heart transplantation in man.
30A
The high frequence ECG: an evaluation of
lead placement. measurement and
reproducibility. 207A
How good is the AHA arrhythmia database
(AHA-ADB) for evaluating CCU
monitors. 206A
Identification by frequency-domain of
patients with bundle branch block at
risk for sustained ventricular
tachycardia. 207A
Monitoring ischemia by intracoronary
electrogram and surface
electrocardiogram during coronary
angioplasty, 223A
Resetting of sustained ventricular
tachycardia with ECG fusion: incidence
and significance. l53A
Transient myocardial ischemia of the
newbom-elinical and ECG evolution.
34A
Electrophysiology
Baroreflex-induced heart rate changes
demonstrate a rate dependent
multicentric origin of the atrial
activation wave. 95A
Can permanent pacemakers be accurately
used to perform programmed electrical
stimulation studies", 199A
Cycle length dependent effects of
procainamide on ventricular
refractoriness, 227A
Divergent frequency-dependent
electrophysiologic changes with
mexiletine and quinidine. 227A
Electrophysiologic correlates of inducible
sustained ventricular tachycardia during
coronary occlusion in dogs with
hypertension and left ventricular
hypertrophy. 96A
Electrophysiologic differences of
atrioventricular nodal reentrant
tachycardia with discontinuous and
continuous antegrade conduction
curves, IOtA
Electrophysiologic mechanisms of the' ' 1:2
response" during atrial
extrastimuJation: elucidation in a pacing
model of the Wolff-Parkinson-White
syndrome. 224A
Electrophysiological and pathological
assessment of chronic first degree
atrioventricular block caused by closed-
chest catheter ablation with
radiofrequency energy in dogs, 95A
Electrophysiologic studies after arterial
switch repair of d-transposition of the
great arteries. 165A
Factors associated with time to arrhythmic
recurrence in survivors of ventricular
fibrillation. 108A
Immediate reproducibility of induced
sustained monomorphic ventricular
tachycardia. 100A
Non-invasive electrophysiology using
permanent pacemakers in patients with
and without ventricular tachycardia or
fibrillation. 167A
Noninvasive termination of sustained
supraventricular and ventricular
tachycardia with external cardiac
programmed stimulation. 200A
Predictive value and efficiency of
programmed electrical stimulation and
Holter monitoring in the management
of ventricular tachycardia and
fibrillation after myocardial infarction.
109A
Prognostic significance of proarrhythrnic
effects during electrophysiologic
testing. 98A
Prognostic significance of programmed
ventricular stimulation in patients at
" low-risk" two weeks after acute
myocardial infarction. 107A
Programmed electrical stimulation in
hypertrophic cardiomyopathy:
stimulation results in patients with and
without cardiac arrest and syncope.
96A
Programmed ventricular stimulation during
myocardial ischemia induced by rapid
atrial pacing. 107A
Prolonged latency and induction of
polymorphic ventricular tachycardia
during electrophysiology testing. 98A
Quality of life of survivors of ventricular
tachycardia or fibrillation who have
undergone intensive electrophysiologic
evaluation. I08A
Reproducibility of arrhythmia induction in
the absence of antiarrhythmic
medications. 109A
Response to programmed electrical
stimulation in reentrant ventricular
tachycardia around the canine mitral
and aortic veins: an in vitro model.
127A
Role of electrophysiologic studies in patients
with hypertrophic cardiomyopathy.
230A
Stability of activation sequence measured by
two ventricular electrodes during
supraventricular tachycardia. 199A
Value of electrophysiologic study in patients
with idiopathic dilated cardiomyopathy
and sustained ventricular
tachyarrhythmias, 107A
ElectrophysiologyI cellular
Altemans of cardiac action potential:
differences between Purkinje and
ventricular muscle fibe rs, 209A
Increased intracellular Ca -t- + may be
important also for early
afterdepolarization, 210A
Rate-related changes in upstroke measured
in single ventricular myocardial cells.
208A
Sodium dependent proton eftlux in human
heart cells. 209A
Embolization
Atrial fibrillation and systemic embolization:
left atrial size strongly predicts risk of
embolization in patients without mitral
stenosis. 220A
Embolism
See Pulmonary embolism
Enalapril
Antiischaemic activity of ACE-inhibitor
Enalapril in normotensive patients with
stable effort angina. 192A
Enalapril in the chronic treatment of
congestive heart failure. 203A
Enalaprilat
Selective coronary vasodilator effect of
enalaprilat in patients with dilated
cardiomyopathy: demonstration by a
bilateral intracoronary infusion
technique. 192A
Encainide
Treatment of AV nodal reentrant tachycardia
with encainide: reversal of drug effect
on the AV node with isoproterenol.
IOIA
Value of dose-titration in the cardiac
arrhythmia pilot study (CAPS). 70A
Endarterectomy
Endarterectomy of the left main coronary
artery using a trans pulmonary artery
approach. Long term angiographic
evaluation. 122A
Non-surgical percutaneous endarterectomy
using a mechanical rotational catheter
in normal coronary arteries in vivo.
188A
Safety of carotid endarterectomy under
regional anesthesia in patients with
coronary artery disease. 23A
Endorphins
Correlation with l3endorphin blood levels
and anginal pain in patients with
coronary artery disease. 176A
Enoximone
Oral MDL17043 in severe cardiomyopathy.
163A
Epidemiology
Epidemiology and prevention of cardiac
failure: Framingharn Study insights,
76A
Epinephrine
Pentobarbital or epinephrine induced
hypokalemia and myocardial
vulnerability in canine infarct model.
11 3A
Synergistic inhibitory effects of aspirin and
ethanol on epinephrine exacerbation of
acute coronary thrombosis formation in
stenosed dog coronary arteries. 189A
Ventricular function after defibrillation is
greater when ischemic, fibrillating
hearts are treated with phenylephrine
rather than epinephrine, l45A
Esmolol
Use of esmolol in patients with acute
myocardial ischemia and
contraindications to beta blockade. 24A
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Ethanol
See also Alcohol
Synergistic inhibitory effects of aspirin and
ethanol on epinephrine exacerbation of
acute coronary thrombosis formation in
stenosed dog coronary arteries, 189A
Excitation
Anodal and cathodal excitation with low and
high currents, 96A
Exercise testing
See also Echocardiography, exercise;
Ambulatory electrocardiography
Abnormal left ventricular response to
exercise in essential hypertension:
relation to obesity and eccentric left
ventricular hypertrophy, 243A
Arrhythmias provoked by exercise stress
testing are independent of clinical
characteristics of patients with
ventricular tachyarrhythmias, 195A
Atrial natriuretic factor during exercise in
human subjects, 234A
Cardiopulmonary exercise performance after
successful percutaneous mitral
valvulotomy, 195A
Cardiorespiratory response to exercise after
definitive repair of univentricular heart,
166A
Changes in mitral flow velocity with
exercise: an index of stress induced
ischemia, 198A
Determination of mitral Doppler cardiac
output during exercise, 198A
Dobutamine: an alternative post infarction
stressor to exercise testing, 121A
Does coronary spasm explain positive
responses during exercise test?, l22A
Earlier onset of ischemia after exposure to
low level carbon monoxide in patients
with ischemic heart disease, 121A
The effect of exercise on the atrial
electrogram in humans, 32A
Effect of an "inotropic" placebo on the
exercise capacity of severe congestive
heart failure patients, 60A
Effect of heart rate on hydraulic work in
heart failure, 43A
An evaluation of the cardiovascular
responses to dynamic exercise after
combined heart and lung
transplantation, 57A
Exercise-enhanced risk factors for coronary
heart disease versus age as criteria for
mandatory retirement of asymptomatic
healthy men, 78A
Exercise-related diastolic dysfunction in
patients with hypertensive left
ventricular hypertrophy, 243A
Exercise testing in patients with automatic
implantable cardioverter defibrillators,
l69A
Hyperthyroid pig: abnormal exercise
responses associated with reduced
coronary reserve, 59A
Incidence of coronary artery disease in male
veteran patients with early positive
treadmill exercise tests, 121A
Independent effect of heart rate variability
controlling for exercise testing in
predicting mortality of 808 patients
after myocardial infarction, 241A
Left ventricular function and blood flow
during exercise in a canine model of
chronic cyanosis, 35A
Long-term exercise performance in
transposition of the great arteries, 165A
Medical versus surgical therapy in patients
with silent myocardial ischemia during
exercise testing, 59A
Nuclear ejection fraction and Doppler
ejection profiles correlate during
exercise in patients with chest pain,
ISA
Oximetry during exercise in children with
cyanotic congenital heart disease, 59A
Peripheral sympathetic activity and
anaerobic metabolism during isotonic
maximal exercise in man, 57A
The prognostic role of exercise testing early
after coronary angioplasty for
multivessel disease, 194A
Rate responsiveness or atrial augmentation
as most important physiological factor
in enhanced exercise performance in
patients with dual chamber pacemakers,
l41A
Regulation of stroke volume during exercise
in patients with severe left ventricular
dysfunction: importance of Starling
mechanism, 58A
Relations between global diastolic function
and exercise tolerance in ischemic left
ventricular dysfunction, 58A
Significance of exercise induced frequent or
repetitive ventricular ectopic beats in
apparently healthy volunteers, 55A
Skeletal muscle and cardiovascular changes
with training in hypertensives on and
off beta adrenergic blockade, 56A
Systolic and diastolic ventricular
performance during supine exercise
following heart transplantation, 57A
Use of thallium stress-redistribution
scintigraphy as a determinant of
prognosis in patients with typical
angina and negative exercise ECG
responses, 139A
Value of submaximal exercise testing after
first anterior infarction in identifying
patients with multivessel disease, 194A
Exercise training
Color flow mapping evaluation of elite
female runners, moderately trained
female runners and sedentary females,
234A
Effect of age on adaptation to aerobic
exercise training, 235A
The effect of training on the physiologic and
structural indices of vascular function,
234A
The interaction of exercise training and beta
blockade in patients with moderate
hypertension, 235A
Long-term exercise training and cardiac
output following cardiac
transplantation, 235A
Fatty acid
The cardiac manifestations in disorders of
fatty acid and carnitine metabolism,
35A
Myocardial free fatty acid oxidation: 14C
palmitate and 14C oleate studies in
humans, 187A
Fenoldopam
Effects of intravenous fenoldopam, a
selective dopamine-I agonist, in severe
or accelerated hypertension, 226A
Fibrillation
See also Atrial fibrillation; Ventricular
fibrillation; Defibrillation
Effect of lesion size on vulnerability, 127A
Fibrinogen
Fibrinogen, cigarette smoking and risk of
cardiovascular disease: insights from
the Framingham Study, 78A
Fibrinolytic defect
Resistance to coronary thrombolysis with
intravenous tissue plasminogen
activator: evidence for a fibrinolytic
defect, 190A
Fibrinolytic therapy
See also Thrombolytic therapy
Fibrin degredation products in ischemic
heart disease: non invasive evidence of
spontaneous fibrinolysis in unstable
angina, 239A
Fish oil
Can oral fish oil supplement minimize
restenosis after percutaneous
transluminal angioplasty?, 64A
Chronic treatment with cod liver oil
facilitates endothelium-dependent
responsiveness in porcine coronary
arteries, 2lOA
The effect of marine oil in conjunction with
other antiplatelet agents on bleeding
time and plasma lipids, 185A
Flecainide
Acute antiarrhythmic effects of flecainide in
ventricular tachyarrhythmias in relation
to left ventricular function, 71A
Efficacy of flecainide in the treatment of
sustained versus nonsustained
ventricular tachycardia, 245A
Efficacy and pharamcokinetics of flecainide
acetate in the treatment of
supraventricular tachycardia in children,
129A
Electrophysiologic effects and clinical
efficacy of flecainide in patients with
ventricular tachycardia, 71A
Flecainide acetate-an effective drug in
paroxysmal atrial fibrillation, 247A
Flecainide acetate in the management of
regular supreventricular tachycardias,
229A
Intravenous and oral flecainide in ectopic
supraventricular tachycardia, 102A
A multicenter, randomized trial of the
efficacy of amiodarone, flecainide,
propafenone in patients with cardiac
disease and complex ventricular
arrhythmias, 48A
Value of dose-titration in the Cardiac
Arrhythmia Pilot study (CAPS), 70A
Flestolol
Electropharmacology of flestolol in patients
with supraventricular tachyarrhythmias,
246A
Flosequinan
Activation of the renin-angiotensin system
limits the long-term hemodynamic and
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clinical responses to the direct-acting
vasodilator. flosequinan, in heart
failure. 120A
Focal events
The map field of view: implications for
recording focal phenomena. 253A
Fontan procedure
See Surgery, pediatric
Gap phenomenon
Phasic vagal discharge and AV nodal gap: a
new mechanism for an old
phenomenon. 253A
Glucose
Increased exogenous glycolytic flux in
ischemic myocardium determined by
positron emission tomography, 73A
Nifedipine enchances glucose metabolism in
rabbit myocardium. 37A
Glycolysis
Mild decreases in regional function and
blood flow: correlations with
isotopically measured glycolysis, 254A
Glycosides
Decreased toxicity with a new semisynthetic
cardiac glycoside: comparison with
digoxin, 133A
Grafts
See also Surgery. coronary artery bypass
Analysis of sequential saphenous vein graft
failure. 123A
Atherosclerotic aneurysm of aorto-coronary
vein graft as a cause of recurrent
myocardial ischemia, 148A
A comparison of morphologic and
angiographic findings in long-term
internal mammary artery and saphenous
vein bypass grafts, 87A
Early and "long term" performanceof
aortic homograft root replacement. 8A
Effect of antiplatelet therapy on early graft
patency after coronary artery bypass
grafting: VA cooperative study #207.
125A
Factors related to atherosclerosis of
saphenous vein coronary bypass grafts.
85A
Immunochemistry of obstructed saphenous
vein-coronary artery bypass grafts.
188A
Implantationof balloon expandable
intravasculargrafts by catheterization in
pulmonary arteries and systemic veins,
131A
Improved heart-lung graft preservation with
prostaglandin E-l, 29A
In vitro cultivation of Iymphocytes from
rejecting cardiac allografts: cell
characterizationand correlation with
biopsy histology, 144A
Long-term function of human cardiac
allografts assessed by two-dimensional
echocardiography, 146A
Non-invasive monitoring of acute rejection
in the cardiac allograft using
radionuclide ventriculography, 5A
Serial evaluations of late changes in 337
vein grafts up to 32 months after
coronary bypass, 87A
Urinary polyamines are markers of cardiac
allograft rejection. 30A
Head-up tilt testing
Unexplained cardiac syncope-role of
vasovagal syndrome. lOA
Heart, artificial
See Artificial heart
Heart block
Criteria for inductionof chronic complete
heart block by His bundle fulguration,
251A
Heart block associated with high magnesium
cardioplegia, 7A
Heart failure
See Congestive heart failure
Heart rate
Does increased heart rate alter LV
contractile state in humans'), 43A
Effect of alcohol on diurnal heart rate
variation, 225A
Effects of increases in heart rate on left
ventricularstroke volume and cardiac
output in the human fetus. 34A
Independent effect of heart rate variability
controlling for exercise testing in
predicting mortality of 808 patients
after myocardial infarction, 24lA
Heart volume
Law of constant heart volume in humans: a
noninvasive assessment via x-ray CT,
MRI and echo, 38A
Hematoporphyrin
Deposition of silver-hematoporphyrin in
atherosclerotic plaque is homogeneous,
intercellular, and confined to plaque,
178A
Hemodialysis
The effects of long term hemodialysis on
cardiac metastatic calcification in
chronic renal failure: assessment by 2D
Doppler echocardiography, 155A
Hemopericarditis
Can hemopericarditis induce ECG injury
pattern", 118A
Heparin
Heparin enchances plasminogen pro-
activator-induced experimental coronary
thrombolysis. 81A
Management of patients with heparin
associated thrombocytopenia and
thrombosis requiring cardiac surgery,
85A
Heptadecanoic acid
1-123 heptadecanoic acid (I-HDA) is an
early marker of myocyte viability in
ischemic-reperfused myocardium. 82A
Histamine
Differential H, and H, receptor mediated
histamine responses of canine
epicardium conductance and distal
resistance vessels. 210A
Holter monitoring
See Ambulatory electrocardiography
Hormones
See Metabolic-hormonal interactions; Sex
hormones; specific hormones
HSP70
Induction of HSP 70 stress protein mRNAs
during cardiac hypertrophy, 38A
Hydralazine
A randomized comparison of hydralazine
and captopril in the treatment of severe
cardiac failure, I03A
Hyperemia
Functional overshoot after brief coronary
occlusions in stunned and normal
myocardium, 94A
Hyperglycemia
Diabetes mellitus and hyperglycemia as risk
factor for cardiovasculardisease:
influence of age and sex. The
Framingham Study, 55A
Hyperlipidemia
The incidence of persistent hyperlipidemias
after coronary artery bypass grafting,
86A
In vivo and in vitro coronary vascular
reactivity in hyperlipidemic swine,
210A
Hypertension
See also Blood pressure; Risk factors
Abnormal left ventricular mechanics and
shape in hypertension in the absence of
ventricularhypertrophy, 52A
Abnormal left ventricular response to
exercise in essential hypertension:
relation to obesity and eccentric left
ventricular hypertrophy, 243A
Blood pressure variability and reactivity in
normotensives and hypertensives under
normal conditions, 115A
Changes in wall thickness but not left
ventricular mass predict improvement
of diastolic filling in hypertension,
244A
Does hypertension cause mitral
regurgitation", 53A
Effects of intravenous fenoldopam, a
selective dopamine-I agonist, in severe
or accelerated hypertension, 226A
Eight year follow-up of participants in the
hypertension detection and follow-up
program: persistenceof reduction in
blood pressure and mortality in a
treated hypertension population, 116A
Enhanced hypoxic pulmonary
vasoconstriction in hypertension, 243A
Exaggerated atrial and ventricular
excitability in hypertensive patients
with isolated septal hypertrophy (ISH),
225A
Fast and safe blood pressure reduction from
sublingual captopril, 226A
Heritability of blood pressure in blacks: twin
studies, 115A
The effect of chronic dobutamine treatment
on the normotensive and hypertensive
heart, 37A
How useful is diastolic blood pressure?
Insights from FraminghamStudy. 114A
Hypertension and late survival in aneurysm
patients, 114A
Hypertension post-cardiac transplantation: is
atrial natriuretic peptide deficiency a
factor in its development. 241A
The impact of blood fluidity on coronary
reserve in patients with hypertensive
heart disease, 53A
Insulin resistance in essential hypertension,
53A
The interaction of exercise training and beta
blockade in patients with moderate
hypertension. 235A
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Is thiazide-produced uric acid elevation
harmful'! Analysis of data from the
hypertension detection and follow-up
program. 227A
Left ventricular diastolic function in
hypertensives, 6A
Prevalence of left ventricular hypertrophy
and diastolic filling abnormalities in
elderly patients with isolated systolic
hypertension. 244A
The progression from high normal blood
pressure to hypertensive levels in the
Framingham Heart Study. 11 5A
Right ventricular adaptation in obese
hypertensive patients. 244A
Skeletal muscle and cardiovascular change
with training in hypertensives on and
off beta adrenergic blockade . 56A
Time course of resolution of pulmonary
hypertension and right ventricular
remodeling after cardiac
transplantation. 31A
Hyperthyroidism
Hyperthyroid pig: abnormal exercise
responses associated with reduced
coronary reserve. 59A
Hypertrophic cardiomyopathy
See also Cardiomyopathy
Age dependent effect of verapamil on end-
diastolic left ventricular function in
patients with hypertrophic
cardiomyopathy. 118A
Apical hypertrophic cardiomyopathy: long-
term clinical and echocardiographic
follow-up. 229A
Clinical identification of amyloid and
hypertrophic cardiomyopathy using
quantitative texture analysis of digital
echocardiographic data. 211A
Contribution of left ventricular contractility
and outflow gradient to ischemia in
hypertrophic cardiomyopathy. 230A
Forearm vasodilator response of patients
with hypertrophic cardiomyopathy:
evidence of a diffuse disorder of
vascular smooth muscle. 230A
Heart rate dependent low-input-Iow output
circulatory failure-the mechanism of
syncope in hypertrophic
cardiomyopathy. 20 lA
Long-term outcome in hypertrophic
obstructive cardiomyopathy after
surgery. 230A
Management of atrial fibri llation in
hypertrophic cardiomyopathy. I17A
Mitral valve replacement in hypertrophic
cardiomyopathy- ten year follow-up in
80 patients. 206A
Non-invasive assessment of the end-systolic
stress-length and stress shortening
relation in hypertrophic
cardiomyopathy. 20 IA
Occurrence and significance of progressive
left ventricular wall thinning and
relative cavity dilatation in patient with
hypertrophic cardiomyopathy. 220A
Postextrasystolic potentiation worsens fast
filling of the hypertrophied left
ventricle in aortic stenosis and
hypertrophic cardiomyopathy. 41A
Programmed electrical stimulation in
hypertrophic cardiomyopathy:
stimulation results in patients with and
without cardiac arrest and syncope.
96A
Relative occurrence of left ventricular wall
thickening and thinning in adult
patients with hypertrophic
cardiomyopathy. 118A
Right ventricular hemodynamic
abnormalities in hypertrophic
cardiomyopathy. 231A
Role of electrophysiologic studies in patienls
with hypertrophic cardiomyopathy.
230A
The simplified Bernoulli equation correctly
predicts outflow tract pressure gradients
in hypertrophic cardiomyopathy: an in
vitro study. 237A
Hypertrophy
Cardiac performance improves after
regression of left ventricular
hypertrophy . 243A
Concentric left ventricular hypertrophy-
when is ventricular ectopic activity
increased" . 226A
Does septal hypertrophy in hypertension
result from combined hemodynamic
overload of the two ventricles", 226A
Exaggerated atrial and ventricular
excitability in hypertensive patients
with isolated septal hypertrophy (ISH).
225A
Exercise-related diastolic dysfunction in
patients with hypertensive left
ventricular hypertrophy. 243A
Expression of the genes encoding the fetal
isoforms of contractile proteins and
atrial natriuretic factor (ANF) in the
hypertrophied adult ventricle. IA
Hypertensive left ventricular hypertrophy. Is
there a high risk sub-group", 114A
Hypertrophy of the noninfarcted
myocardium following myocardial
infarction in humans. A beneficial
adaptation . 43A
Induction of HSP 70 stress protein mRNAs
during cardiac hypertrophy. 38A
Left ventricular hypertrophy and
hypertension accelerates the rate of
infarction. 79A
Minimal coronary vascular resistance in
atrial hypertrophy. 169A
Myocardial energetics and tolerance (0
ischemic arrest in hypertrophied hearts.
145A
Regression of the infundibular hypertrophy
after pulmonary valvuloplasty in
patients with suprasystemic pressure of
the right ventricle . 75A
Regression of left ventricular hypertrophy
after renal transplantation. 52A
Hypokalemia
Hypokalemia by l3-adrenergic stimulation in
the coronary circulation of the dog.
92A
Pentobarbital or epinephrine induced
hypokalemia and myocardial
vulnerability in a canine infarct model.
II3A
Hypoplastic left heart syndrome
What is the fate of the tricuspid valve
following palliative surgery for
hypoplastic left heart syndrome", l32A
Hypo xia
The effects of acute hypoxia and
reoxygenation on function and
metabolism of the isolated neonatal
heart. 35A
Negative chronotropic effects of hypoxia on
the automaticity in the rabbit sinus
node. 252A
Ouabain potentiated hypoxic cardiac
contracture. 171 A
Sodium-23 NMR prediction of reversibility
of function following hypoxia in the
isolated perfused rat heart. 72A
Ibuprofen
Ibuprofen: a potent antithrombotic agent for
arterial injury after balloon angioplasty,
MA
Imipramine
Value of dose-titration in the Cardiac
Arrhythrnias Pilot Study (CAPS). 70A
Indium-lll
Intracoronary distribution of l l l-ln-Iabeled
platelets in dogs with experimental
coronary stenosis. 254A
Indoramin
Antiarrhythmic effects of indoramin, an
alphaj-adrenoreceptor antagonist during
regional ischemia and reperfusion of
isolated perfused rat hearts. 157A
Differing effects of ai -adrenergic blockade
with prazosin and indoramin on
coronary flow during exercise. 255A
Inosine
Inosine improves recovery of "stunned"
myocardium after transient ischemia.
126A
Inotropic therapy
See also specific agents
Ambulatory inotropic therapy as a bridge to
cardiac transplantation. 89A
The new positive inotropic agents
functionally block N, the inhibitory
regulator of adenylate cyclase, 2A
Nonuniform transmural response of the
" stunned" myocardium to inotropic
stimulation. 145A
Insulin
Insulin resistance in essential hypertension.
53A
Interleukln-I
Interleukin-I (IL-I) induced cardiac
dysfunction in an in-vitro isolated
perfused heart preparation. 143A
Iridium-191m
Simultaneous assessment of regional
ventricular function and perfusion
utilizing iridium-191m and thallium-
201, 4A
Irradiation
Coronary artery disease after chest
irradiation. 176A
Ischemia
See also Myocardial ischemia
Detection of subendocardial ischemia by
recording endocardial electrograms
during pacing induced angina. 70A
Earlier onset of ischemia after exposure to
low level carbon monoxide in patients
with ischemic heart disease. 121A
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Effects of acute ischemia and reperfusion on
myocardial l3-adrenoreceptors and
adenylate cyclase activity, 80A
Features of ischemia during daily activities
in patients with and without previous
myocardial infarction, 241A
Impaired prostacyclin (PGb) receptor
function in acute ischemic heart
disease, 193A
Monitoring ischemia by intracoronary
electrogram and surface
electrocardiogram durcoronary
angioplasty, 223A
Prognostic significance of ischemic episodes
on Holter monitoring during daily
activities: 2 years follow-up of 356
patients, 240A
Relations between global diastolic function
and exercise tolerance in ischemic left
ventricular dysfunction, 58A
Reliability of stress Doppler
echocardiography in the detection of
ischemia in humans during different
forms of stress, 17A
Silent and symptomatic ischemia after
angioplasty: detection with continuous
and realtime ST segment monitoring.
68A
Isometric twitch
Prolongation of isometric twitch with stretch
of normal human muscle. 40A
Isoproterenol
The differential effects of isoproterenol on
sustained ventricular tachycardia before
and during antiarrhythmic therapy.
227A
Effects of acute ischemia and reperfusion on
myocardial l3-adrenoreceptors and
adenylate cyclase activity. 80A
Effects of isoproterenol on atrial latency and
atrial arrhythmias, IOIA
Treatment of AV nodal reentrant tachycardia
with encainide: reversal of drug effect
on the AV node with isoproterenol,
IOIA
Isosorbide dinitrate
Nitrate resistance: failure of intravenous
nitrate to reduce elevated left
ventricular filling pressure in acute
myocardial infarction, a common and
unpredictable phenomenon. 23A
Isosorbide-5-mononitrate
Duration of effects of isosorbide-5-
mononitrate in angina pectoris. 134A
Ketanserin
Ketanserin, a serotonergic and alphar-
adrenergic antagonist, blocks cardiac
Na+ channels and lengthens
repolarization, 156A
Lactate dehydrogenase
Marginal benefits of LDH and LDH
isoenzymes in diagnosis of myocardial
infarction: are they worth it? 22A
Lasers
Argon laser ablation with a new silica ball-
tip device, 187A
Comparison of acute and chronic effects of
argon and excimer laser energy on
chronic aorta. 178A
Coronary artery laser angioplasty without
perforation using a sapphire lens tipped
optical fiber, 221A
Early and late healing responses of canine
arterial wall to excimer laser
irradiation. 85A
Intraoperative mapping-guided argon laser
ablation of malignant supraventricular
and ventriculartachycardia. 249A
Intraoperative Nd: YAG laser
photocoagulative ablation of ventricular
tachycardia: observations relevant to
transcatheterablation techniques, 249A
Laser angioplasty in atherosclerotic swine:
recanalization of occluded iliac arteries
using a glass fiber "ball tip," l89A
Laser balloon angioplasty: thermal profile
for in vitro welding of neointimal
arterial separations, I05A
Laser-enhanced angioplasty: early clinical
experience, 178A
Laser photoablation of atherosclerotic
plaque: comparison of CO2 and mid-
infrared lasers, l89A
Laser probe ablation of normal aorta and
plaque. Correlation of thermographic
and histologic findings. I04A
Lensed fibers for laser assisted balloon
angioplasty, 177A
Percutaneous coronary laser angioplasty in a
large animal model of human coronary
atherosclerosis. I04A
Percutaneous coronary laser thermal
angioplasty with a metallic capped
fiber, I04A
A pulsed ultraviolet Alexandrite laser for
angioplasty: evaluation of tissue
ablation and fiberoptic conduction.
188A
Quantitationof lumen enlargementduring
coronary angioplasty using pressure-
volume curves vs. arteriography, 105A
Reductions in peak pulse energy diminish
particulate debris resulting from
excimer laser plaque ablation, 105A
LDH
See Lactate dehydrogenase
Leukotoxin
Leukotoxin, a new myocardial depressive
agent,42A
Lidocaine
Antifibrillatory effects of high-dose
bretylium and a lidocaine-bretylium
combinationduring cardiac arrest and
cardiopulmonary resuscitation. 228A
Lidocaine. a new inhibitor of neutrophil
superoxide anion release. significantly
reduces infarct size in pigs, 81A
Modulation of lidocaineeffects on
ventriculardefibrillation, 166A
Procainamide does not affect ventricular
defibrillation in dogs. 166A
Lidoflazine
Effect of acute or chronic administration of
calcium antagonists on mortality
following myocardial infarction, 24A
Lipids
See also Cholesterol
Effect of plasma lipids on restenosis
following coronary angioplasty, 183A
Lipoprotein
See Cholesterol
Lisinopril
Persistent hemodynamic effects of lisinopril
after chronic therapy in congestive
heart failure. I04A
Lithotripsy
The effects of extracorporeal shock wave
lithotripsy on pacemaker function. 32A
Loading conditions
Atrial natriuretic factor is a marker for
cardiac volume overload in humans
with asymptomatic left ventricular
dysfunction. 117A
Differing responses in ventricular filling,
loading and volumes during positive
end-expiratory pressure (PEEP), 4lA
Effect of alteration of afterload on the
functional border zone. 146A
Maximum coronary blood flow beyond a
coronary artery stenosis is reduced by
an acute increase in left ventricular
afterload, 254A
Lysophosphatidyl choline
Lysophosphatidyl choline: probable agent
for maintained triggered activity in
ischemiccardiac Purkinje fibers, 252A
Magnesium
Heart block associated with high magnesium
cardioplegia, 7A
Magnesium sulfate
Effectiveness of magnesium sulfate in
torsade de pointes: a study of 9
patients, 245A
Magnetic resonance imaging
See Nuclear magnetic resonance imaging
Mapping
See also Color Doppler flow imaging
Color flow mapping evaluation of elite
female runners. moderately trained
female runners and sedentary females.
234A
Colored quadrant mapping
electrocardiography in the evaluation of
myocardial infarction, 223A
Extent of endocardial excision during
ventricular tachycardia surgery guided
by sinus rhythm late potential maps
versus ventricular activation maps, 97A
Relationship and significance of the terminal
activities seen on signal-averaged body
surface maps and epicardial activation
maps in canine myocardial infarction,
l26A
Marine oil
See Fish oil
MDL 17043
See Enoximone
Metabolic-hormonal interactions
Which patients with congestive heart failure
have malignant ventricular
tachyarrhythmias? Potential metabolic-
hormonal interactions in high-risk
subsets. 33A
Methoxamine
Receptor stimulated acceleration of
phosphatidylinositol response enhances
atrial natriuretic polypeptide release in
isolated adult rat atrial myocytes, 134A
Metroprolol
Apparently idiopathic sustained ventricular
tachycardia responsive to metoprolol in
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young patients: histologic evidence of
silent cardiomyopathy, 102A
Infarct size reduction and recovery of
systolic function following coronary
thrombolysis (tissue-type plasminogen
activator) combined with beta
adrenergic blockade (metoprolol), 81A
Mexiletine
Divergent frequency-dependent
electrophysiologic changes with
mexiletine and quinidine, 227A
Effect of oral mexiletine-quinidine
combination therapy on ventricular
function, 72A
Mitral insufficiency
Variability of color flow mapping Doppler
imaging of regurgitant jets in an animal
model of mitral insufficiency, MA
Mitral regurgitation
Cardiac cine magnetic resonance imaging:
detection of mitral and aortic
regurgitation, 159A
Color flow Doppler study of the effects of
afterload on the spatial distribution of
mitral regurgitant jets, 67A
Comparative evaluation of Doppler
techniques and auscultation for
detection of mitral regurgitation (MR),
238A
Depressed ventricular function in chronic
experimental mitral regurgitation, 40A
Does hypertension cause mitral
regurgitation", 53A
Hemodynamic implications of jet size by
color Doppler flow imaging in patients
with mitral regurgitation, 67A
Inability of the end-systolic stress/end-
systolic volume index ratio to predict
postoperative outcome in chronic mitral
regurgitation, 85A
Mitral regurgitation after percutaneous mitral
valvotomy in adults: evaluation by
pulsed Doppler echocardiography,
217A
Mitral repair is the procedure of choice for
mitral regurgitation: an intraoperative
2-D echo study, 84A
The physiology of mitral regurgitation:
vortex formation in the left atrium, 67A
Pure severe mitral regurgitation (MR) in
rheumatic heart disease-relative
prevalence, mechanisms and relation to
disease activity, 9A
Total and regional myocardial blood flow in
chronic experimental mitral
regurgitation, l69A
Mitral stenosis
Aid of echocardiography in balloon
valvuloplasty for aortic stenosis and
mitral stenosis, 217A
Mechanism of increase in mitral valve area
by double-balloon catheter balloon
valvuloplasty in adults with mitral
stenosis: echocardiographic-Doppler
correlation, 217A
Mitral valve area
Is average mitral orifice area required for
calculation of Dopplerl2D echo cardiac
output", 18A
Determination of mitral Doppler cardiac
output during exercise, 198A
Failure of the Doppler pressure halftime to
accurately demonstrate change in mitral
valve area following percutaneous
mitral valvotomy, 218A
Mitral valve prolapse
Echocardiographic abnormalities associated
with autosomal dominant polycystic
kidney disease, 9A
Etiology of chest pain in patients with mitral
valve prolapse, 9A
Mitral valve prolapse: additional support for
the "normalcy" of displacement in the
apical 4-chamber view only, 9A
Prevalence of mitral valve prolapse by two-
dimensional echocardiography: a
population based study, 77A
Ventricular tachycardia in patients with
"idiopathic" mitral valve prolapse:
histologic demonstration in associated
primary myocardial abnormalities, 8A
Monoclonal antibody
A monoclonal antibody against
coxsackievirus B4 which cross-reacts
with the V-I isoform of myosin:
implication for autoimmunity, 145A
OKT3 monoclonal antibody for early
prophylaxis in cardiac transplantation,
30A
Moricizine
Efficacy of moricizine in patients with
decreased left ventricular function and
recurrent ventricular tachycardia, 229A
Value of dose-titration in the Cardiac
Arrhythmia Pilot Study (CAPS), 70A
Myocardial function
Effects of blood ionized calcium on
myocardial mechanics in humans, 6A
Mild decreases in regional function and
blood flow: correlations with
isotopically measured glycolysis, 254A
Myocardial function preserved by
allopurinol given systematically or in
cardioplegic solution, 88A
Reduction in regional myocardial function at
rest in conscious dogs with chronically
reduced regional coronary artery
pressure, 253A
Myocardial infarct size
Dissociation between infarct reduction and
myocardial expansion with reperfusion,
93A
Improved clot lysis and infarct size
reduction with coronary venous
compared to intravenous infusion of
streptokinase, 82A
Left ventricular ejection fraction: a predictor
of myocardial infarct size with anterior
but not inferior wall infarction, 175A
Lidocaine, an inhibitor of neutrophil
superoxide anion release, significantly
reduces infarct size in pigs, 81A
Quantification of acute myocardial infarct
size using thallium-20 I single photon
emission computed tomography:
comparison with CK-MB sizing, 174A
Validation of infarct sizing by
echocardiographic 3-D endocardial
surface mapping in human autopsy
hearts, 219A
Western Washington intravenous
streptokinase (SK) in myocardial
infarction: radionuclide ventricular
function and infarct size, 60A
Myocardial infarction, acute
See also Angioplasty, coronary;
Thrombolytic therapy
Assessment of sympathetic innervation after
transmural versus nontransmural
myocardial infarction, 138A
Basis for increased mortality in women after
myocardial infarction, 56A
Cardiothoracic surgical support is required
during interventional therapy of
myocardial infarction: results from the
TAMI study, 124A
Circadian increase in platelet aggregability:
association with the time of increased
frequency of myocardial infarction and
sudden cardiac death, 239A
Comparison of predictive value of admission
2-D echocardiography and
hemodynamics in acute myocardial
infarction, 158A
Complications during air transport of
patients with acute myocardial
infarction, 22A
Coronary morphology demonstrates a
common link between unstable angina
and non-Q wave infarction, 196A
Economic benefits of an occupational work
evaluation soon after myocardial
infarction, 24A
Effect of acute or chronic administration of
calcium antagonists on mortality
following myocardial infarction, 24A
Electrocardiographic and enzymatic findings
in non-Q wave infarction: results of the
multicenter prospective randomized
diltiazem reinfarction study, 224A
Evolution of late potentials during the first
10 days after acute myocardial
infarction, 224A
The impact on coronary disease mortality of
an intervening nonfatal myocardial
infarction during patient followup, 77A
Is the "threshold" phenomenon for
detecting myocardial infarction by
regional left ventricular wall motion
analysis artificial", 220A
Leti ventricular hypertrophy and
hypertension accelerates the rate of
infarction, 79A
Magnetic resonance and thallium 201
myocardial imaging: a segment to
segment comparison in patients with
myocardial infarction and ischemia,
75A
Marginal benefits of LDH and LDH
isoenzymes in diagnosis of myocardial
infarction: are they worth it", 22A
Multivariate analysis of hospital mortality in
acute myocardial infarction patients
undergoing interventional
catheterization, 233A
Myocardial infarction associated with
cocaine use, 25A
Myocardial infarction in the absence of
angiographically significant coronary
atherosclerotic disease: long-term
prognosis, I72A
The natural history of ST elevation
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following uncomplicated anterior MI,
224A
The natural history of ventricular late
potential activity in acute myocardial
infarction, 151A
Pentobarbital or epinephrine induced
hypokalemia and myocardial
vulnerability in a canine infarct model,
113A
Persistent ST segment elevation after
uncomplicated acute anterior
myocardial infarction: prevalence and
clinical significance, 173S
Plasma levels of atrial natriuretic factor in
acute myocardial infarction in man,
248A
Platelet inhibition, coagulation variables and
left ventricular thrombi in acute
myocardial infarction, 189A
Prognostic value of left ventricular ejection
fraction in patients with or without left
ventricular failure after myocardial
infarction, 23A
Relationships and significance of the
terminal activities seen on signal-
averaged body surface maps and
epicardial activation maps in canine
myocardial infarction, 126A
Residual stenosis in evolving myocardial
infarction/a randomized study of
APSAC v. streptokinase, 231A
Scintigraphic evidence of sympathetic
denervation in canine myocardial
infarction, 138A
Seasonal variation in sudden arrhythmic
death in dogs with acute myocardial
infarction: a three year retro-pro-
spective study, 127A
Serial analysis of spontaneous and induced
ventricular arrhythmias in a canine
model of myocardial infarction, 91A
Significance of the direction of ST deviation
on admission in patients evolving non-
Q wave myocardial infarction, 23A
The significance of recannulation on
reperfusion imaging in acute
myocardial infarction, 26A
Tensile strength and protein composition of
healing myocardial infarct in the pig,
80A
A thin subendocardial infarction produced
cholinergic denervation of overlying
normal epicardium, 94A
Myocardial injury
Determination of optimal time and pulse
sequence for enhanced detection of
acute myocardial injury following
gadolinium-DTPA: a nuclear magnetic
resonance imaging study, 74A
Myocardial ischemia
Atherosclerotic aneurysm of aorto-coronary
vein graft as a cause of recurrent
myocardial ischemia, 148A
Bedside detection of silent ischemia using a
12 lead programmable ECG monitor:
value of a multi-lead system, 223A
Changes in mitral flow velocity with
exercise: an index of stress induced
ischemia, 198A
Characteristics of silent myocardial ischemia
during mental stress: laboratory
assessment using equilibrium
radionuclide ventriculography, 5A
Contribution of left ventricular contractility
and outflow gradient to ischemia in
hypertrophic cardiomyopathy, 230A
Doppler echocardiographic study of left
ventricular diastolic filling in ischemia:
effect on reperfusion on mitral flow
velocity, 214A
Early detection of silent ischemia using
ambulatory monitoring and intervention
to reduce ischemic burden, 207A
Echocardiographic posterior left ventricular
dyskinesis seen in the upright position
in healthy volunteers, 216A
Effect of atrial natriuretic peptide on
coronary blood flow and myocardial
performance, 242A
The effect of regional myocardial ischemia
on Doppler echo indices of global left
ventricular performance: influence of
heart rate, afterload, and the size of
ischemic zone, 2l9A
Effects of titrating beta adrenergic blockade
dose on silent myocardial ischemia in
ambulatory patients, 68A
Enhancement of ischemic myocardial
recovery by coronary vasodilatory
effects of prostacyclin, 88A
Greater dysfunction of non-ischemic
myocardium during acute anterior vs.
inferior transmural ischemia, 92A
Increased exogenous glycolytic flux in
ischemic myocardium determined by
positron emission tomography, 73A
Increased sensitivity of 1-123
phenylpentadecanoic acid in the
identification of exercise-induced
myocardial ischemia, 25A
Magnetic resonance and thallium 201
myocardial imaging: a segment to
segment comparison in patients with
myocardial infarction and ischemia,
75A
Medical versus surgical therapy in patients
with silent myocardial ischemia during
exercise testing, 59A
Metabolic response of ischemic myocardium
to early reperfusion for transmural
myocardial infarction, 189A
Modulation of coronary constriction by
myocardial ischemia, 186A
Myocardial dysfunction during chronic rapid
ventricular pacing. Role of myocardial
ischemia, 155A
Nuclear magnetic resonance imaging of
myocardial ischemia during
dipyridamole effect in a partial
coronary artery stenosis model, 74A
Prognostic importance of myocardial
ischemia detected by ambulatory
monitoring in patients with coronary
disease, 68A
Reactivity to mental stressors in
asymptomatic patients with coronary
disease and silent myocardial ischemia,
175A
Silent ischemia after myocardial infarction,
68A
Silent myocardial ischemia is frequent in
post coronary bypass patient, 124A
Subcellular distribution and potential loci of
release of arachidonate: implications for
myocardial ischemic injury, 38A
Transient myocardial ischemia of the
newborn-clinical and ECG evaluation,
34A
Use of esmolol in patients with acute
myocardial ischemia and
contraindications to beta blockade, 24A
Myocardial metabolism
Influence of nitroglycerin on myocardial
metabolism monitored by laser
fluorimetry during human left heart
catheterization, 193A
Myocardial perfusion
Assessment of myocardial perfusion by
contrast enhanced digital subtraction
echocardiography, ll2A
Assessment of myocardial perfusion in vivo
using nuclear magnetic resonance
imaging, 45A
Contrast echocardiography during cardiac
catheterization to assess regional
myocardial perfusion in humans, 113A
Impact of distal coronary perfusion on
ejection fraction response to balloon
inflation during PTCA, 69A
Quantitative myocardial perfusion imaging
using contrast 2-dimensional
echocardiography, ll2A
Spontaneous reduction in myocardial
perfusion deficit defined by contrast
echocardiography during infarction,
219A
Sustained improvement of myocardial
perfusion three months after
thrombolysis assessed by thallium-20l,
173A
Validation of regional myocardial perfusion
by cine CT, 160A
Myocardial relaxation
Left ventricular diastolic function during
ventricular tachycardia: effect of {3-
adrenergic receptor activation on
myocardial relaxation, 202A
Myocardial substrate
Dichotomous myocardial substrate utilization
reflecting reperfusion, 37A
Myocardial viability
Gated RP-30 perfusion study after stress
predicts myocardial viability, 27A
Myocarditis
Eosinphilic myocarditis in heart transplant
recipient hearts, l44A
The focal nature of myocarditis: a limiting
factor in endomyocardial biopsy
diagnosis, 154A
Immune-mediated myocarditis in the guinea
pig model: histology and mechanical
and sarcoplasmic reticular function,
147A
Patients with the acquired immunodeficiency
syndrome and histopathological
myocarditis frequently manifest major
clinical cardiac abnormalities, l54A
Myocardium
Acoustic microscopy of normal and
myopathic human myocardium:
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implications for ultrasonic tissue
characterization, 211A
The relationship of function, ultrastructure,
and energy state of human
myocardium, 39A
Myocardium, "stunned"
Functionalovershoot after brief coronary
occlusions in stunned and normal
myocardium, 94A
Inosine improves recovery of "stunned"
myocardium after transient ischemia,
126A
Isovolemic relaxation and systolic
contraction of postischemic stunned
myocardium: divergent effects of
verapamil, 93A
Metabolic identification of stunned canine
myocardium by positron emission
tomography, 73A
Myocardial blood flow and oxygen
consumption in stunned myocardium,
125A
Nonuniform transmural response of the
"stunned" myocardium to inotropic
stimulation, 145A
Prolonged post-ischemic dysfunction after
repetitive brief coronary occlusions
interspersed with reperfusions through a
critical stenosis, 188A
Myocyte
1-123 heptadecanoic acid (I-HDA) is an
early marker of myocyte viability in
ischemic reperfused myocardium, 82A
Regional variation in myocyte diameter: a
clue to early left ventriculardysfunction
in aortic insufficiency?, 22A
Myosin
A monoclonal antibody against
coxsackievirus 84 which cross-reacts
with the V-I isoform of myosin:
implication for autoimmunity, 145A
Ni
The new positive inotropic agents
functionally block N; the inhibitory
regulator of adenylate cyclase, 2A
Nadolol
Early experience with nadolol in children
with supraventricular tachycardia, 129A
Nicardipine
Calcium entry blockers and alpha-mediated
vasoconstriction: effect of verapamil
and nicardipine in human forearm,
IMA
Effects of intracoronary nifedipine and
nicardipineon left ventricular inotropy
and relaxation, l63A
Nifedipine
Comparativeeffects of intravenous vs
intracoronary nifedipine in man:
evidence for negative inotropism, 163A
Effect of acute or chronic administration of
calcium antagonists on mortality
following myocardial infarction, 24A
Effects of diltiazem-nifedipine, and their
combinationon transient ST-segment
deviations on the ambulatory ECG in
patients with stable angina, 177A
Effects of intracoronary nifedipine and
nicardipineon left ventricular inotropy
and relaxation, 163A
Nifedipine enhances glucose metabolism in
rabbit myocardium, 37A
Nisoldipine
Evidence that the coronarydilator effects of
the calcium antagonist nisoldipine are
preservedduring long-term treatment,
l63A
Nitrates
See a/so specific agents
Nitrate resistance: failure of intravenous
nitrate to reduce elevated left
ventricular filling pressure in acute
myocardial infarction, a common and
unpredictable phenomenon, 23A
Nitroglycerin
Does the intermittent administration of
nitroglycerin prevent the development
of hemodynamic tolerance in patients
with severe heart failure". I03A
Does tolerancedevelop to the coronary
artery dilation effects of nitrates, 177A
An experimental plea for the use of
nitroglycerin in the treatmentof acute
aortic insufficiency, 84A
Incidence of early tolerance to continuous
intravenous nitroglycerin infusion in
patients with coronary artery disease
and heart failure, I03A
Influence of nitroglycerin on myocardial
metabolism monitored by laser
fluorimetry during human left heart
catheterization, 193A
NMR
See Nuclear magnetic resonance imaging
Norepinephrine
Involvement of norepinephrine kinetics one
year post orthoptic cardiac
transplantation and normalization of
responses to orthostatic stress, 221A
Mechanisms of experimental ventricular
pacing-induced heart failure: role of
myocardial norepinephrine and
sarcoplasmic reticulum calcium
ATPase, 17la
Relation between left and right ventricular
function and norepinephrine in plasma
and myocardium in patients with
primary dilated cardiomyopathy, 116A
Nuclear magnetic resonance imaging
Assessment of myocardial perfusion in vivo
using nuclear magnetic resonance
imaging, 45A
Automated left ventricularmass, volume
and shape from three-dimensional
magnetic resonance imaging: in vitro
validation, 46A
Cardiac cine magnetic resonance imaging:
detection of mitral and aortic
regurgitation, l59A
Changes in proton NMR relaxation times
with reflow after a brief myocardial
ischemic insult, 73A
Comparison of Doppler and nuclear
magnetic resonance imaging for
measurements of volume flow, 19A
Complementary role of magnetic resonance
imaging and real-time Doppler color
flow mapping for post-op evaluation
after surgery for tetralogy of Fallot,
165A
Concordance of right and left ventricular
stroke volume measurements in normal
subjects by Cine MRI, 46A
Determination of optimal time and pulse
sequence for enhanced detection of
acute myocardial injury following
Gadolinium-DTPA: a nuclear magnetic
resonance imaging study, 74A
Enhanced blood-pool contrast in cardiac
nuclear magnetic resonance imaging,
45A
Fast dynamic MRI studies of flow in
congenital heart disease: initial
experience, 160A
In vivo phosphorus31 and sodium 23
magnetic resonance spectroscopy during
coronary occlusion and reperfusion in
cat hearts, 72A
Magnetic resonance imaging versus
thallium-201 myocardial perfusion
studies in patients with a recent
myocardial infarction, 74A
Magnetic resonance and thallium-201
myocardial imaging: a segment to
segment comparison in patients with
myocardial infarction and ischemia,
75A
Measurement of ventricular volumes by
magnetic resonance imaging, 46A
Nuclear magnetic resonance imaging of
myocardial ischemia during
dipyridamole effect in a partial
coronary artery stenosis model, 74A
Protective effect of pretreatmentwith
aniparnil in the ischemic-reperfused rat
heart,72A
Quantification of valvular regurgitation by
Cine MRI, 84A
Sodium-23 NMR prediction of reversibility
of function following hypoxia in the
isolated perfusion rat heart, 72A
Spatially localizedflow measurementby
nuclear magnetic resonance imaging,
46A
T, and T2 changes with severe flow
reduction at 24 and 72 hours after
coronary occlusion in dogs, 74A
Obesity
Electrocardiographic left atrial abnormalities
indicate diastolic ventricular
dysfunction in obesity, 113A
A prospective study of obesity as a risk
factor for fatal and non-fatal coronary
heart disease in women, 79A
14C Oleate
Myocardial free fatty acid oxidation: '4C
palmitate and 14C oleate studies in
humans, l87A
Ouabain
Ouabain potentiated hypoxic cardiac
contracture, 171 A
Oximetry
Oximetry during exercise in children with
cyanotic heart disease, 59A
Oxygen free radicals
Early toxic effects of oxygen free radicals
on myocardial energy metabolism
following reperfusion, 125A
Oxygen free radicals mediate arachidonate
induced platelet aggregation and
thromboxane 82 production, 2A
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Oxygen transport
Importance of 2,3-diphosphoglyceric acid to
oxygen transport in congestive heart
failure, 186A
Oxygenutilization
Assessment of regional myocardial oxygen
utilization by positron tomography with
"Cvacerate. 73A
Oxygenation
See also Reoxygenation
Effect of dobutamine infusion on serum
electrolytes and arterial oxygenation in
congestive heart failure, 34A
Pacemakers
Abandonment of pacemaker leads, 31A
Antitachycardia pacemaker and automatic
implantable cardioverter defibrillator as
sole therapy for ventricular tachycardia,
140A
Can permanent pacemakers be accurately
used to perform programmed electrical
stimulation studies?, 199A
The effects of extracorporeal shock wave
lithotripsy on pacemaker function, 32A
Epicardial ventricular pacemaker lead
longevity in children, 37A
Lead end of life and the need for elective
replacement, 31A
Long-term efficacy and complications of
antitachycardia pacemakers compared
with implantable defibrillators, 143A
Monitoring of physiologic variables from
mixed venous blood for use in
algorithms to control rate responsive
pacemakers, IlA
Non-invasive electrophysiology using
permanent pacemakers in patients with
and without ventricular tachycardia or
fibrillation.167A
Rate responsiveness or atrial augmentation
as most important physiological factor
in enhanced exercise performance in
patients with dual chamber pacemakers,
141A
Use of an automatic antitachycardia
pacemaker in pediatric postoperative
patients, 199A
Pacing, cardiac
Adaptive antitachycardia pacing for
ventricular tachycardia, 140A
The beneficial hemodynamic effect of rapid
atrial pacing in severe acute aortic
regurgitation (AR), 84A
Characteristics of entrainment of
orthodromic circus movement
tachycardia during autodecremental
atrial and ventricular stimulation, 152A
Effect of atrial pacing on left ventricular
diastolic filling measured by pulsed
Doppler echocardiography. 197A
The effect of AV simultaneous pacing on
the retrograde Kent bundle conduction
in patients with concealed WPW
syndrome, l2A
Effect of different activities on the rate
response of activity triggered rate
responsive pacing, IIA
The effect of exercise on the atrial
electrogram in humans, 32A
Hemodynamic effects of rate responsive
pacing in patients with left ventricular
dysfunction measured by 2D and
Doppler echocardiography, II A
Influence of ventricular rate at rest and
exercise during AV sequential and
ventricular pacing using radionuclide
ventriculography. lOA
Interruption of spontaneous and induced
tachyarrhythmias by scanning self-
adapting overdrive pacing, 141A
Long-term pacing in sinus node disease:
superiority of atrial stimulation, lOA
Myocardial dysfunction during chronic rapid
ventricular pacing. Role of myocardial
ischemia, 155A
Pacing at an atrioventricular interval that
increases right atrial pressure also
increases atrial refractoriness, 10IA
Prospective evaluation of ventricular pacing
and high energy transvenous shocks
using a triple electrode array for
cardioversion of ventricular
tachycardia, 141A
Subthreshold atrial pacing in the termination
of orthodromic reciprocating
tachycardia in patients with left-sided
bypass tracts, 198A
Superior bipolar sensing, 31A
Transmural activations and potentials with
endocardial and epicardial pacing, 32A
Unexplained cardiac syncope-role of
vasovagal syndrome. lOA
14C Palmitate
Myocardial free fatty acid oxidation: 14C
palmitate and 14C oleate studies in
humans, 187A
Patentductus arteriosus
Catheter closure of patent ductus arteriosus
(PDA) , 131A
Color Doppler flow mapping of pulmonary
artery flow in an animal model of
patent ductus arteriosus, 3A
Detection and quantitation of constriction of
the fetal ductus arteriosus by Doppler
echocardiography, 2A
Diastolic retrograde renal artery blood flow
in premature neonates with respiratory
distress syndrome and patent ductus
arteriosus, 4A
Foreign body retrieval: transcatheter removal
of embolized patent ductus arteriosus
occlusion devices and catheter pieces,
130A
Simultaneous catheter and CW Doppler
pressure gradients with patent ductus
arteriosus: PA pressure prediction,
128A
Substantial improvement in noninvasive
diagnosis of coarctation and
differentiation from patent ductus:
Doppler evaluation of descending aortic
waveform patterns, 3A
Pediatric cardiology
See also specific defects or diseases;
Arrhythmias, pediatric; Surgery,
pediatric
Age is a better predictor of left ventricular
mass index than blood pressure in
normal adolescents, 5 IA
Altered fetal circulation in diabetic
pregnancies, 34A
The cardiac manifestations of disorders of
fatty acid and carnitine metabolism,
35A
Cardiodensity response to exercise after
definitive repair of univentricular heart,
166A
Diastolic filling in LV outflow obstruction
pre and post balloon angioplasty, 130A
Early experience with nadolol in children
with supraventricular tachycardia, 129A
The effects of acute hypoxia and
reoxygenation on function and
metabolism of the isolated neonatal
heart, 35A
Effects of increases in heart rate on left
ventricular stroke volume and cardiac
output in the human fetus, 34A
Efficacy and pharmacokinetics of f1ecainide
acetate in the treatment of
supraventricular tachycardia in children,
129A
Estimation of pulmonary artery pressure in
children with ventricular septal defect:
real-time color flow/continuous wave
Doppler application, 128A
Genetic effects of left ventricular mass on
blood pressure in children. 52A
High density-lipoprotein cholesterol and
apolipoprotein A-I levels in children:
interrelationship and correlates in the
Bogalusa heart study, 55A
The importance of body weight as a
determinant of cardiac structure and
function in adolescents, 52A
Intra-atrial reentrant tachycardia in children:
clinical and electrophysiologic features,
management and follow-up, 129A
Left ventricular false tendons and Still's
murmur of childhood: a causative
association?, 128A
Left ventricular function and blood flow
during exercise in a canine model of
chronic cyanosis. 35A
Pulsed Doppler echocardiographic detection
of tricuspid insufficiency in children,
130A
Sex hormones and blood pressure levels in
white and black children: the Bogalusa
Heart Study. 55A
Transient myocardial ischemia of the
newborn-clinical and ECG evolution,
34A
Pentobarbital
Pentobarbital or epinephrine induced
hypokalemia and myocardial
vulnerability in canine infarct model,
II3A
Pentoxifylline
Efficacy of pentoxifylline in chronic stable
angina pectoris, 176A
Peptide 6A
Restoration of coronary blood flow by
peptide 6A in a canine model of
intracoronary thrombus, 136A
Peptide receptor
The vasoactive intestinal peptide receptor is
coupled to adenylate cyclase and
muscle contraction in human ventricular
myocardium, 137A
Perfusion
See Myocardial perfusion; Reperfusion
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Pericardial effusions
Superior vena cava flow velocity patterns
can diagnose cardiac tamponade in
patients with pericardial effusions.
118A
Pericarditis
Central venous flow velocity patterns can
differentiate constrictive pericarditis
from restrictive cardiomyopathy. 119A
Constrictive pericarditis and restrictive
cardiomyopathy differentiation by
Doppler recording of atrioventricular
flow velocities. 17A
Pericardium
The normal pericardium does not affect
ventricular function. 117A
Peripheral vascular disease
Dynamic angioplasty as a treatment
modality in peripheral vascular disease:
the first clinical results. 180A
Extent of coronary disease in patients with
cerebrovascular and peripheral vascular
disease. 77A
Phenylephrine
Ventricular function after defibrillation is
greater when ischemic. fibrillating
hearts are treated with phenylephrine
rather than epinephrine, 145A
Phenylpentadecanoic acid
Increased sensitivity of 1-123
phenylpentadecanoic acid in the
identification of exercise-induced
myocardial ischemia. 25A
Relationship between 1-123
phenylpentadecanoic acid myocardial
uptake and coronary flow in dogs with
partial coronary artery occlusions.
138A
Phenytoin
Pharmacokinetic interaction between
amiodarone and phenytoin. 47A
Phosphatidylinositol
Receptor-stimulated acceleration of
phosphatidylinositol response enhances
atrial natriuretic polypeptide release in
isolated adult rat atrial myocytes, 134A
Piriprost
Piriprost (U-60. 257B) modulates eicosanoid
formation and reduces myocardial
neutrophil accumulation in infarct size
in rats. 80A
Pirmenol
Efficacy of pirmenol, a new antiarrhythmic
agent in terminating supraventricular
tachycardia. 247A
Electrophysiologic and electrocardiographic
effects of pirmenol in patients with
ventricular tachycardia. 228A
Plasminogen activator
See a/so Thrombolytic therapy
Abrupt recurrent thrombosis after
intravenous tissue plasminogen
activator and emergency coronary
angioplasty in acute myocardial
infarction. 232A
Ancrod enhances the thrombolytic effect of
urokinase and recombinant tissue-type
plasminogen activator. l35A
Can intrinsic tissue type plasminogen
activator beconcentrated at the site of a
thrombus? 81A
Chronic cigarette smoking inhibits tissue
plasminogen activator (t-PA) in plasma.
56A
Coronary angioplasty following rt-PA in
acute myocardial infarction: a report
from the thrombolysis in myocardial
infarction (TIMI) trial, 231A
Early administration of recombinant tissue
plasminogen activator (rt-PA). The
NHLBI thrombolysis in myocardial
infarction (TlM!) study. 190A
Emergent coronary bypass preserves left
ventricular function following
intravenous tissue plasminogen
activator therapy for acute myocardial
infarction. 191A
Heparin enhances plasminogen pro-activator-
induced experimental thrombolysis.
81A
Improved left ventricular function following
intravenous recombinant tissue type
plasminogen activator in acute
myocardial infarction. 190A
Infarct size reduction and recovery of
systolic function following coronary
thrombolysis (tissue-type plasminogen
activator) combined with beta
adrenergic blockade (rnetoprolol), 81A
A randomized multicenter trial of
intravenous plasminogen activator and
emergency coronary angioplasty: results
from the TAMI Study Group. 231A
A randomized, placebo-controlled trial of
recombinant tissue-type plasminogen
activator trt-Pa) for unstable angina
pectoris. 239A
Resistance to coronary thrombolysis with
intravenous tissue plasminogen
activator: evidence for a fibrinolytic
defect. I90A
Reversal of right ventricular dysfunction in
patients with acute pulmonary
embolism after treatment with
intravenous tissue plasminogen
activator. 40A
Rural hospital administration of intravenous
tissue plasminogen activator in acute
myocardial infarction: improved timing.
efficacy and ventricular function. 61A
Thrombolytic treatment of acute myocardial
infarction with intracoronary
administration of plasminogen pro-
activator. 190A
Platelets
Intracoronary distribution of III-In-Iabeled
platelets in dogs with experimental
coronary stenosis. 254A
Platelet activating factor
Effect of platelet activating factor on the
isolated guinea pig heart. 136A
Platelet aggregation
Circadian increase in platelet aggregability:
association with the time of increased
frequency of myocardial infarction and
sudden cardiac death. 239A
Duration of smoking-induced enhancement
of platelet aggregation. 172A
Enzymatic monitoring in dilated
cardiomyopathy: evidence for cardiac
platelet accumulation. 144A
Increase in epinephrine-induced platelet
aggregation with adverse kinetics of
platelet adrenergic receptors in patients
with ischemic heart disease. 240A
Oxygen free radicals mediate arachidonate
induced platelet aggregation and
thromboxane B2 production. 2A
Platelet inhibition
Platelet inhibition coagulation variables and
left ventricular thrombi in acute
myocardial infarction. 189A
Polyamines
Urinary polyamines are markers of cardiac
allograft rejection. 30A
Polypeptides
Isolation and characterization of a
myocardial polypeptide that is
mitogenic for fibroblasts, 155A
Positive end-expiratory pressure
Differentiating responses in ventricular
filling. loading and volumes during
positive end-expiratory pressure
(PEEP).4IA
Post-extrasystolic potentiation
The mechanism of post-extrasystolic
potentiation in normal and myopathic
human myocardium. 147A
Postpericardiotomy syndrome
The effective treatment of
postpericardiotomy syndrome following
cardiac surgery: a randomized placebo
controlled trial, 124A
Potassium
Transient inward current of the rabbit
atrioventricular node induced by low
K + concentration. 209A
Prazosin
Differing effects of ol-adrenergic blockade
in prazosin and indoramin on coronary
flow during exercise. 255A
The renin angiotensin aldosterone system
does not contribute to the development
of tolerance in heart failure during
prazosin treatment. 120A
Prednisone
Efficacy of prednisone therapy for new onset
idiopathic dilated cardiomyopathy.
143A
Long-term function of human cardiac
allografts assessed by two-dimensional
echocardiography, 146A
Pre-excitation
Loss of preexcitation following
procainamide does not predict risk of
sudden death in Wolff-Parkinson-White
syndrome. IIA
Procainamide
Cycle length dependent effects of
procainamide on ventricular
refractoriness, 227A
Loss of preexcitation following
procainamide does not predict risk of
sudden death in Wolff-Parkinson-White
syndrome. IIA
Procainamide does not affect ventricular
fibrillation in dogs. 166A
Risk of conversion from non-inducible to
inducible ventricular tachycardia by
procainamide in patients with dilated
heart failure. 246A
Propafenone
The electrophysiologic effects of
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propafenone on the immature
mammalian heart, 36A
A multicenter, randomized trial on the
efficacy of amiodarone, f1ecainide and
propafenone in patients with cardiac
disease and complex ventricular
arrhythmias, 48A
Propafenone in ventricular tachyarrhythmias:
long-term clinical efficacyand
predictive value of programmed
electrical stimulation, Holter monitoring
and exercise testing, 244A
Propranolol
Are calcium antagonists as effective as beta
blockers for the treatmentof
thyrotoxicosis?, 164A
A comparison of celiprolol to propranolol in
angina pectoris: results of an
international double-blind study, 192A
Effect of propranolol and verapamil during
infant orthodromic reciprocating
tachycardia, 36A
Use of exercise Doppler to evaluate cardiac
drugs: comparative influence of beta
and calcium blockers on aortic
acceleration and velocity, 18A
Prostacyclin
Atherosclerotic arteries produce more
prostacyclin and thromboxane than
normal arteries, 170A
Enhancement of ischemic myocardial
recovery by coronary vasodilatory
effects of prostacyclin, 88A
Impaired prostacyclin (PGb) receptor
function in acute ischemic heart
disease, 193A
Lack of antithrombotic efficacyof high dose
aspirin relative to low dose aspirin is
restored by PGb infusion, 136A
Prostaglandins
Improved heart-lung graft preservation with
prostaglandin E-l, 29A
Prosthesis
See Artificial heart; Valve prosthesis;
Coronary endoprosthesis
Protamine
Complementactivation after protamine
administration following coronary
angioplasty, 180A
Protein kinase C
Protein kinase C inducedcalcium-dependent
slow action potentials in rat atrial
myocytes, 209A
Pulmonary artery pressure
Estimation of pulmonaryartery pressure in
children with ventricularseptal defect:
real-timecolor flow/continuous wave
Doppler application, 128A
Simultaneous catheter and CW Doppler
pressure gradients with patent ductus
arteriosus: PA pressure prediction,
128A
Pulmonary embolism
Reversalof right ventriculardysfunction in
patients with acute pulmonary
embolism after treatment with
intravenous tissue plasminogen
activator, 40A
Thrornbin-antithrombin III complex:
diagnostic value in pulmonary
embolism, 248A
Pulmonary intravascular volume
Selective alpha and beta adrenergic
regulation of pulmonary intravascular
volume, 170A
Q waves
Clinical significance of disappeared Q-waves
following myocardial infarction: a
correlative two-dimensional
echocardiographic and
electrocardiographic study, 158A
Quinidine
Divergent frequency-dependent
electrophysiologic changes with
mexiletine and quinidine, 227A
Effect of oral mexiletine-quinidine
combination therapy on ventricular
function, 72A
Radionuclide studies
See Angiography, radionuclide;
Scintigraphy; specific radionuclide
agent; Ventriculography, radionuclide
Recainam
Effects of a new class I drug (recainam) on
spontaneous and induced ventricular
tachycardias in consciousdogs with
subacute myocardial infarction, 228A
Recannulation
The significance of recannulation on
reperfusion imaging in acute
myocardial infarction, 26A
Reflexes
See also Cardiovascular reflexes
Reflex responses to lower body negative
pressureare markedly impaired in heart
failure patients before and after cardiac
transplantation, 147A
Renin
Atrial natriuretic peptide released by rapid
atrial pacing is associated with
suppression of plasma renin activity,
I7IA
Effects of l3-adrenergic stimulation on atrial
natriuretic peptide and plasma renin in
the dog, 242A
Renin-angiotensin-aldosterone system
The renin angiotensin aldosterone system
does not contribute to the development
of tolerance in heart failure during
prazosintreatment, 120A
Renin-angiotensin system
Activation of the renin-angiotensin system
limits the long-term hemodynamic and
clinical flosequinan in heart failure,
120A
Refractory period
Effects of cycle length and activation
sequenceon canine ventricular
refractory periods, 94A
Reocclusion
Abrupt reocclusion in PTCA: angiographic
characteristics and clinical
consequences. l81A
Frequency of coronary reocclusion after
successful intracoronary thrombolysis in
acute myocardial infarction: comparison
of immediate PTCA with subsequent
medical treatment, 232A
Symptomatic and silent reocclusion
following combinedstreptokinase and
successful coronary angioplasty in acute
myocardial infarction, 173A
Reoxygenation
The effects of acute hypoxia and
reoxygenation on function and
metabolism of the isolatedneonatal
heart, 35A
Reperfusion
See also Revascularization
Dichotomous myocardial substrate utilization
reflecting reperfusion, 37A
Direct angioplasty in acute myocardial
infarction-benefit of late reperfusion
in patients with collateral flow, 191C
Dissociation between infarct reduction and
myocardial expansion with reperfusion,
93A
Early toxic effects of oxygen free radicals
on myocardial energy metabolism
following reperfusion, 125A
The effect of coronary reperfusion on the
survival of patients with cardiogenic
shock due to acute myocardial
infarction, 233A
Effects of acute ischemia and reperfusioaon
myocardial l3-adrenoreceptors asd
adenylate cyclase activity, 80A
Endothelial cell dysfunction: an important
mechanism in the evolution of
reperfusion injury, 125A
Intracoronary adenosine markedly reduces
infarct size and improves ventricular
function in a canine reperfusion model,
126A
Metabolic response of ischemic myocardium
to early reperfusion for transmural
myocardial infarction, 189A
Rapid ultrasound enhancement of reperfused
myocardium by f1uorocarbon emulsion,
126A
Reduction of reperfusion injury by rapid
acting coenzymeQI0 administered
intravenously just prior to reperfusion,
93A
The second Mt. Sinai-NYU reperfusion trial:
main endpoints, 239A
The significance of recannulation of
reperfusion imaging in acute
myocardial infarction. 26A
Respiratory distress syndrome
Diastolic retrograde renal artery blood flow
in premature neonates with respiratory
distress syndrome and patent ductus
arteriosus, 4A
Res&enosis
Can oral fish oil supplement minimize
restenosis after percutaneous
transluminal coronary angioplasty?,
MA
Coronary wedge pressure: a predictorof
restenosis after angioplasty, 184A
Early angiographic changes after
percutaneous transluminal coronary
angioplasty, 181 A
Early radionuclide angiography identifies
low risk patients for late restenosis after
transluminal coronary angioplasty, 5A
Early restenosis and repeat coronary
angioplasty, 63A
Early results, complications and restenosis
rates after multilesion and multivessel
coronary angioplasty, 14A
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Effect of plasma lipids on restenosis
following coronary angioplasty. 183A
Incidence of restenosis at I. 2. 3 and 4
months after successful coronary
angioplasty: a quantitative angiographic
follow-up study in 345 patients. 63A
Percutaneous translurninal coronary
angioplasty: relationship between
restenosis and inflation times, 64A
Percutaneously implantable endo-coronary
prosthesis: preliminary results in the
treatment of dilatation re-stenosis,
106A
Repeat restenosis: efficacy of the third and
fourth coronary angioplasty, 63A
Restenosis following successfulcoronary
angioplasty: a multivariable analysis of
patient, procedure and coronary lesion-
related risk factors, l84A
Stress testing and thallium scintigraphy as
predictors of restenosis after successful
coronary angioplasty. 184A
Revascularization
See also Angioplasty, coronary; Grafts;
Reperfusion; Surgery, coronary artery
bypass; Thrombolysis
Does extent of revascularization influence
prognosis in patients with three-vessel
disease", l22A
Effect of completeness of revascularization
on outcome in patients with unstable
angina undergoing percutaneous
transluminal coronary angioplasty,
150A
Functionallydirected revascularization using
coronary angioplasty: an alternative
approach in the management of
multivessel disease. 15A
Myocardial revascularization using both
internal mammary arteries. 87A
Postischemic ATP levels fail to correlate
with regional functional recovery after
surgical revascularization of acute
infarction, 89A
Selection of patients for coronary
angiography following acute myocardial
infarction, 193A
Rheumatic heart disease
Pure severe mitral regurgitation (MR) in
rheumatic heart disease-relative
prevalence, mechanisms and relation to
disease activity, 9A
Ribose
Effect of ribose on post ischemic thallium
201 kinetics. 25A
Influence of risk region size on function of
nonischemic myocardium during acute
transmural ischemia. 146A
Risk factors
Diabetes mellitus and hyperglycemia as risk
factors for cardiovasculardisease:
influence of age and sex. The
Framingham Study. 55A
Exercise-enhanced risk factors for coronary
heart disease versus age as criteria for
mandatory retirement of asymptomatic
healthy men, 78A
Fibrinogen, cigarette smoking and risk of
cardiovasculardisease: insights from
the Framingham study. 78A
Physician recognitionof coronary risk
factors: a disparity between approach to
hypertension and hypercholesterolemia
in patients hospitalized on a medicine
service, 79A
Prospective cardiac risk stratification prior to
non-cardiac geriatric surgery. 194A
A prospective study of obesity as a risk
factor for fatal and non-fatal coronary
heart disease in women. 79A
Risk factors of right heart failure (RHF)
after orthotopic heart transplantation
(HTX),90A
Rose Questionnaire
Poor predictive value of the London School
of Hygiene Cardiovascular (Rose)
Questionnaire for the diagnosis of
angina pectoris compared with
thallium-201 imaging, 78A
RP-30
Gated RP-30 perfusion study after stress
predicts myocardial viability. 27A
Initial clinical results with 99m TC
methoxyisobutyl isonitrile. 28A
Myocardial kinetics of technetium-99m
hexakis-2-methoxy-2-methylpropyl-
isonitrile: a new cardiac imaging agent.
26A
Quantitativecomparison of planar and
tomographic Tc-99m MIBI (RP-30) and
TL-201 myocardial perfusion
scintigraphy in patients with coronary
disease for perfusiondefect intensity
and defect reversibility. 27A
Quantitativecomparison of TL-201 with Tc-
99m MIBI (RP-30), 27A
Rest-exercise organ distribution of RP-30, a
new technetium-99m-labeled
myocardial perfusion imaging agent.
27A
Scintigraphy
See also Radionuclide studies; specific
scintigraphic agent
Scintigraphic evidence of sympathetic
denervation in canine myocardial
infarction, 138A
Scintigraphic progression of coronary artery
disease after single vessel acute
myocardial infarction, 139A
Sex hormones
Sex hormones and blood pressure levels in
white and black children: the Bogalusa
Heart Study. 55A
Sickle cell anemia
Abnormal ventriclar filling in sickle cell
anemia,58A
Signal averaging
Absence of changes in body surface maps of
signal-averaged late activity in patients
with ventricular tachycardiaafter
antiarrhythmic drugs, 152A
A comparativestudy of frequency-and time-
domain analysis of signal averaged
ECGs in ventriculartachycardia. 208A
Optimal interval to predict ventricular
tachycardia based on frequency analysis
of the signal averaged
electrocardiogram. 208A
Signal averaged ECG predicts the
inducibility of sustained ventricular
tachycardia in patients with
spontaneous nonsustained tachycardia,
151A
The signal averaged electrocardiogram in
patients with ventriculartachycardia
and bundle branch block. 208A
Signal averaging predicts inducibility of
sustained ventricular tachycardia in
patients with high grade ectopy and
non-sustained ventricular tachycardia,
15lA
Sinus node disease
Long-term pacing in sinus node disease.
Superiority of atrial stimulation, lOA
Sinus node function
Effect of antihistamines on sinus node
function and atrioventricular conduction
in response to rapid atrial pacing in
cardiac transplant patients, 96A
Smoking
Chronic cigarette smoking inhibits tissue
plasminogen activator (I-PAl in plasma,
56A
Duration of smoking-induced enhancement
of platelet aggregation. l72A
Fibrinogen. cigarette smoking and risk of
cardiovasculardisease: insights from
the Framingham Study. 78A
Sodium
Sodium dependent proton efflux in human
heart cells, 209A
Sodium channel
Amiodarone binds to the type I
antiarrhythmic drug receptor on the
cardiac sodium channel. SOA
Sodium channel blockers
See specific agent
Sotalol
Antiarrhythmic effects of the class III drug
d-sotalol on recurrent sustained
ventricular tachycardiadiscordance with
beta blocker sotalol, 229A
Antiarrhythmic effects of d-sotalol in
patients with refractory supraventricular
tachyarrhythmias, 49A
A comparison of atenolol and sotalol in the
treatment of patients with paroxysmal
supraventricular tachycardia. 247A
A comparison of the clinical
electrophysiology of intravenous and
oral sotalol, 49A
Efficacy of oral sotalol for sustained
ventricular tachycardia refractory to
Type I antiarrhythmic drugs. 49A
Oral sotalol: electrophysiologic effects and
long term efficacy in patients with
recurrent supraventricular tachycardia.
49A
Sotalol for sustained ventricular tachycardia
and/or sudden death, SOA
SPECT
Effect of maintenance oral theophylline
therapy on dipyridamole thallium
myocardial imaging using SPECT and
dipyridamole-induced hemodynamic
changes. 139A
Specificity of SPECT TL-201 myocardial
imaging in women: improvement by
adjusting for breast attenuation, l40A
Sphygmomanometers
Testing the accuracy of automated and
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semiautomatedsphygmomanometers
designed for home use, 113A
SQ 30217
Rest and exercise myocardial perfusion
scans and clearance rates of SQ 30217,
a new technetium-99m perfusion
imaging agent, 138A
ST segment
Effects of diltiazem-nifedipine, and their
combination on transient ST-segment
deviations on the ambulatory ECG in
patients with stable angina pectoris,
I77A
Is ST segment elevation a valid ECG
criterion for thrombolysis selection in
acute myocardial infarction, 61A
The natural history of ST elevation
following uncomplicated anterior Ml,
224A
Persistent ST segment elevation after
uncomplicated acute anterior
myocardial infarction: prevalence and
clinical significance. 173A
Prognostic importance of myocardial
ischemia detected by ambulatory
monitoring in patients with coronary
disease, 68A
Significance of the direction of ST deviation
on admission in patients evolving non-
Q-wave myocardial infarction, 23A
Significance of painless ST segment
depression during low level exercise
testing early after acute myocardial
infarction, 194A
Silent and symptomatic ischemia after
angioplasty: detection with continuous
and real-time ST segment monitoring,
68A
Starling mechanism
Regulation of stroke volume during exercise
in patients with severe left ventricular
dysfunction: importanceof Starling
mechanism, 58A
Steroids
See also specific agents
High-dose steroids for prevention of
recurrent restenosis post-PTCA: a
randomized trial, 185A
Still's murmur
Left ventricular false tendons and Still's
murmur of childhood: a causative
association, 128A
Streptokinase
See also Thrombolytic therapy
Excess risk of reinfarction after
streptokinase: experience from
I.S.A.M., a prospective placebo
controlled double blind multicenter trial
in acute myocardial infarction, 60A
Improved clot lysis and infarct size
reduction with coronary venous
compared with intravenous infusion of
streptokinase, 82A
Influence of vessel involvement and timing
of streptokinase therapy on left
ventricular function in acute myocardial
infarction, 191A
Intravenous (i.v.) APSAC versus
intracoronary streptokinase in the
treatment of acute myocardial
infarction, 63A
Residual stenosis in evolving myocardial
infarction: a randomized study of
APSAC v. streptokinase, 231 A
Reversedistribution is a good prognostic
sign following intravenous streptokinase
during acute myocardial infarction, 26A
Serial angiographic analysis of ventricular
function recovery after intracoronary
streptokinase, 61A
The significance of recannulation on
reperfusion imaging in acute
myocardial infarction, 26A
Symptomatic and silent reocclusion
following combined streptokinase and
successfulcoronary angioplasty in acute
myocardial infarction, 173A
Temporal changes in wall motion following
intravenous streptokinase during acute
myocardial infarction. 157A
Thrombolysis-combined rotational catheter
thrombectomy followed by intra-arterial
streptokinase: evaluation by angioscopy
and angiography, 82A
Western Washington intravenous
streptokinase (SK) in myocardial
infarction: radionuclide ventricular
function and infarct size. 60A
Stress testing
See Exercise testing
Stressors, mental
Reactivity to mental stressors in
asymptomatic patients with coronary
disease and silent myocardial ischemia.
175A
Stroke
Alcohol and stroke, 78A
Stroke volume
See also Ventricular stroke volume
Regulation of stroke volume during exercise
in patients with severe left ventricular
dysfunction: importance of Starling
mechanism, 58A
Sudden death
Baroreflex sensitivity and sudden death in
conscious dogs before and after
myocardial infarction, 80A
Circadian increase in platelet aggregation:
association with the time of increased
frequency of myocardial infarction and
sudden cardiac death. 239A
Loss of preexcitation following
procainamide does not predict risk of
sudden death in Wolff-Parkinson-White
syndrome. IIA
A new non-invasive index to predict
sustained ventricular tachycardia and
sudden death in the first year post-
myocardial infarction: a prospective
study,24A
Seasonal variation in sudden arrhythmic
death in dogs with acute myocardial
infarction: a three year retro-prospective
study, I27A
Sotalol for sustained ventricular tachycardia
and/or sudden death. 50A
Sulfinpyrazone
Effect of antiplatelet therapy on early graft
patency after coronary artery bypass
grafting: VA cooperative study #207,
l25A
Sulmazole
The new positive inotropic agents
functionally block Ni, the inhibitory
regulator of adenylate cyclase, 2A
Superior vena cava
Superior vena cava flow velocity patterns
can diagnose cardiac tamponade in
patients with pericardial effusions,
118A
Supraventricular tachyarrhythmias
Antiarrhythmic effects of d-sotalol in
patients with refractory supraventricular
tachyarrhythmias, 49A
Electropharmacology of flestolol in patients
with supraventricular tachyarrhythmias,
246A
Supraventricular tachycardia
Atrial natriuretic factor in atrial fibrillation
and during supraventricular tachycardia.
33A
Biatrial isolation with preservation of normal
sinus node function and sino-ventricular
conduction: a surgical treatment for
supraventricular tachycardias, IOOA
A comparison of atenolol and sotalol in the
treatment of patients with paroxysmal
supraventricular tachycardia, 247A
Discrete cryosurgical ablation of
atrioventricularnode reentry
tachycardia in patients, 249A
Early experience with nadolol in children
with supraventricular tachycardia, 129A
ECG criteria for ventricular and
supraventricular tachycardia in wide
complex tachycardias with left bundle
branch morphology, 206A
Efficacy and pharmacokinetics of flecainide
acetate in the treatment of
supraventricular tachycardia in children.
129A
Efficacy of piremenol, a new antiarrhythmic
agent in terminating supraventricular
tachycardia, 247A
Flecainide acetate in the management of
regular supraventricular tachycardias,
229A
Intraoperative mapping-guided argon laser
ablation of malignant supraventricular
and ventricular tachycardia, 249A
Intravenous and oral flecainide in ectopic
supraventricular tachycardia, 102A
Noninvasive terminationof sustained
supraventricular and ventricular
tachycardia with external cardiac
programmed stimulation, 200A
Oral sotalol: electrophysiologic effects and
long term efficacy in patients with
recurrent supraventricular tachycardia,
49A
Stability of activation sequence by two
ventricularelectrodes during
supraventricular tachycardia. 199A
Surgery, cardiac
See also specific procedures
Amiodarone therapy in cardiac and
noncardiac surgery, 90A
Biatrial isolation with preservation of normal
sinus node function and sino-ventricular
conduction: a surgical treatment for
supraventricular tachycardias, IOOA
The quality of life and arrhythmia status
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after surgery for Wolff-Parkmson-White
syndrome: an 18 year perspective.
IOOA
Surgical treatment of progressive rest angina
pectoris: multivariate stepwise
discriminant analysis of factors
influencing ten year survival. 87A
WPW surgery interrupts efferent vagal
innervation to the canine left ventricle.
IOOA
Surgery, coronary artery bypass
See also Grafts
Cardiothoracic surgical support is required
during interventional therapy of
myocardial infarction: results from the
TAMI study. 124A
Changing profile of the coronary bypass
patient, 123A
Clinical features which predict high cost of
coronary artery bypass surgery
(CABS). 86A
Current coronary artery surgery practices: a
national survey. l23A
Effect of coronary bypass surgery on
survival of patients with resuscitated
cardiac arrest: a CASS Registry Study.
14l!A
Emergency surgery after failed angioplasty.
123A
Emergent coronary bypass preserves left
ventricular function following
intravenous tissue plasminogen
activator therapy for acute myocardial
infarction. 191A
The incidence of persistent hyperlipidemias
after coronary artery bypass grafting.
86A
The left ventricular end-diastolic volume as
a marker of high mortality after
coronary artery bypass surgery. 86A
Medical versus surgical therapy in patients
with silent myocardial ischemia during
exercise testing. 59A
Morbidity and mortality associated with
emergency bypass graft surgery
following elective coronary angioplasty.
124A
Preoperative non-invasive carotid evaluation
of coronary artery bypass patients. 86A
Silent myocardial ischemia is frequent in
post coronary bypass patient. )24A
Subthreshold atrial pacing in the termination
of orthodromic reciprocating
tachycardia in patients with left-sided
bypass tracts. 198A
Triple vessel coronary artery endarterectomy
and reconstruction. 122A
Surgery, pediatric
See also Transposition of the great arteries
An association between vascular changes on
lung biopsy specimens and
postoperative morbidity following the
Fontan procedure. 204A
Balloon valvuloplasty for isolated aortic
stenosis in children- short-term results.
130A
Cardiorespiratory response to exercise after
definitive repair of univentricular heart.
166A
Implantation of balloon expandable
intravascular grafts by catheterization in
pulmonary arteries and systemic veins.
131A
Normalization of right ventricular diastolic
filling after arterial switch procedure.
204A
Post operative evaluation after end-to-end
subclavian left coronary artery
anastomosis in Bland-White-Garland
syndrome. 205A
Predictive factors for development of
chronic effusions following modified
Fontan procedure-do they exist?
204A
Repair of atrioventricular canal defects
utilizing Carpentier reconstructive
techniques. 205A
Results of the management of patients with
transposition of the great arteries in the
current era. 203A
Right and left ventricular function 10 years
after Mustard operation for
transposition of the great arteries. 204A
Serial Doppler echocardiographic assessment
of tricuspid regurgitation following
repair of ventricular septal defect in
early infancy: possible relation to
operative approach. 205A
Use of an automatic antitachycardia
pacemaker in pediatric postoperative
patients. I99A
Valve replacement in children: guidelines
for selection of prosthesis. I64A
What is the fate of the tricuspid valve
following palliative surgery for
hypoplastic left heart syndrome". 132A
Surgery, valvular
See also Valve prostheses; Valvotomy;
Valvuloplasty
Atrial activity during cardioplegia and
postoperative arrhythmias. 7A
Early " long term" performance of aortic
homograft root replacement. 8A
Initial experience with triiodothyronine (n)
therapy in patients with low cardiac
output following open heart surgery.
7A
Mitral repair is the procedure of choice for
mitral regurgitation: an intraoperative
2-0 echo study. 84A
Mitral valve replacement in hypertrophic
cardiomyopathy- ten year follow-up in
80 patients. 206A
Sympathetic nervous system
Electrocardiographic effects of sympathetic
imbalance. 95A
Peripheral sympathetic activity and
anaerobic metabolism during isotonic
maximal exercise in man. 57A
Syncope
Unexplained cardiac syncope-role of
vasovagal syndrome. lOA
Syndrome X
Abnormalities of coronary flow reserve and
esophageal motility in syndrome X: a
systemic disorder of smooth muscle
reactivity. 249A
High dose dipyridamole-echocardiography
test in patients with syndrome X. 221A
Systole
Inability of the end-systolic stress/end-
systolic volume index ratio to predict
postoperative outcome in chronic mitral
regurgitation. 85A
Tachyarrhythmias
See also Tachycardia; Ventricular
tachyarrhythmias
lnterruption of spontaneous and induced
tachyarrhythmias by scanning self-
adapting overdrive pacing. 141A
Tachycardia
See also Ventricular tachycardia;
Supraventricular lachycardia
Cardiac Doppler flows during fetal
dysrhythmias: studies of post
extrasystolic potentiation and recovery
from tachycardia. 35A
Characteristics of entrainment of
orthodromic circus movement
tachycardia during autodecremental
atrial and ventricular stimulation. 152A
Discrete cryosurgical ablation of
atrioventricular node reentry
tachycardia in patients, 249A
Effect of propranolol and verapamil during
infant orthodromic reciprocating
tachycardia. 36A
Electrophysiologic differences of
atrioventricular nodal reentrant
tachycardia with discontinuous and
continuous antegrade conduction
curves. IOIA
Entrainment as a guide for localizing the site
of ventricular tachycardia. 153A
Importance of the effect of verapamil or
refractory period of the atrioventricular
node in preventing induction of circus
movement tachycardia utilizing a
bypass pathway. 246A
Intra-atrial reentrant tachycardia in children:
clinical and electrophysiologic features.
management and follow-up, 129A
A new criterion reliably distinguishes
atrioventricular nodal reentrant from
septal bypass tract tachycardias, 12A
The physiologic substrate for antidromic
reciprocating tachycardia: prerequisite
characteristics of the accessory pathway
and atrioventricular node. 12A
Subthreshold atrial pacing in the termination
of orthodromic reciprocating
tachycardia in patients with left-sided
bypass tracts. 198A
Treatment of AV nodal reentrant tachycardia
with encainide: reversal of drug effect
on the AV node with isoproterenol.
IOIA
Variations of autonomic tone in train
stimulation for prevention of
atrioventricular reentrant tachycardia.
199A
Technetium·99m
See also RP-30
Comparative myocardial transport of
technetium labeled SQ 30.217
(cardiotonic) and thallium-201. 137A
Flow-distribution characteristics of Tc-99m-
hexakis-2-methoxy, 2-methylpropyl
isonitrite in animal models of
myocardial ischemia and reperfusion,
137A
Quantitative comparison of planar and
tomographic Tc-99m MIBI (RP-30) and
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TL-201 myocardial perfusion
scintigraphy in patients with coronary
disease for perfusion defect and
intensity and defect reversibility. 27A
Quantitative comparison of TI-201 with Tc-
99m MIBI (RP-30), 27A
Rest and exercise myocardial perfusion
scans and clearance rates of SQ
30.2 17. a new technetium-99m
perfusion imaging agent. 138A
Tetralogy of Fallot
Complementary role of magnetic resonance
imaging and real-time Doppler color
flow mapping for post-op evaluation
after surgery for tetralogy of Fallot.
165A
Detachable latex balloon occlusion of
anomalous systemic arteries in patients
with tetralogy of Fallot. 131 A
Only 8% of post operative tetralogy patients
have inducible ventricular
dysrhythmias. 36A
TIlallium-201 imaging
See also Dipyridamole
Assessment of sympathetic innervation after
transmural versus nontransmural
myocardial infarction. 138A
Can exercise two dimensional
echocardiography replace exercise
thallium imaging, 216A
Comparative myocardial transport of
technetium labeled Sq 30. 217
(cardiotec) and thallium-201. 137A
Effect of ribose on post ischemic thallium-
201 kinetics. 25A
Factors effecting reported sensitivity and
specificity of exercise thallium
scintigraphy. a meta-analysis, 120A
False positive TL20 I defects in left bundle
branch block: relationship to left
ventricular dilatation, 139A
Magnetic resonance imaging versus
thallium-20I myocardial perfusion
studies in patients with a recent
myocardial infarction. 74A
Magnetic resonance and thallium 201
myocardial imaging: a segment to
segment comparison in patients with
myocardial infarction and ischemia.
75A
Poor predictive value of the London School
of Hygiene Cardiovascular (Rose)
Questionnaire for the diagnosis of
angina pectoris compared to thallium-
201 imaging. 78A
Quantification of acute myocardial infarct
size using thallium-20I single photon
emission computed tomography:
comparison with CK-MB sizing. 174A
Quantitative comparison of planar and
tomographic Tc-99m MIBI (RP-30) and
TL-201 myocardial perfusion
scintigraphy in patients with coronary
disease for perfusion defect and
intensity and defect reversibility. 27A
Quantitative comparison of TI-20 I with Tc-
99m MIBI (RP-30). 27A
The significance of recannulation on
reperfusion imaging in acute
myocardial infarction, 26A
Simultaneous assessment of regional
ventricular function and perfusion
utilizing iridium-19lm and thallium-
201. 4A
Staged percutaneous transluminal coronary
angioplasty (PTCA) in patients with
multivessel disease: use of stress TI2111
imaging. 26A
Stress testing and thallium scintigraphy as
predictors of restenosis after successful
coronary angioplasty, 184C
Use of thallium stress-redistribution
scintigraphy as a determinant of
prognosis in patients with typical
angina and negative exercise ECG
responses, 139A
Theophylline
Effect of maintenance oral theophylline
therapy on dipyridamole thallium
myocardial imaging using SPECT and
dipyridamole-induced hemodynamic
changes. 139A
Thiazide diuretics
Is thiazide-produced uric acid elevation
harmful? analysis of data from the
hypertension detection and follow-up
program. 227A
Thrombectomy
Thrombolysis-combined rotational catheter
thrombectomy followed by intra-arterial
streptokinase: evaluation by angioscopy
and angiography, 82A
Tltrombin-antithrombin III complex
Thrombin-antithrombin 111 complex:
diagnostic value in pulmonary
embolism. 248A
Thrombocytopenia .
Management of patients with heparin
associated thrombocytopenia and
thrombosis requiring cardiac surgery.
85A
Thrombogenesis
Analysis of blood flow velocity and
thrornbogenesis in left atrial appendage
by transesophageal two dimensional
echocardiography , 212A
Thrombolytic therapy
See also specific agents
Angioscopy guided coronary thrombolysis ,
62A
Cost benefit analysis of intracoronary
thrombolytic therapy: 12 months
follow-up report of a randomized trial.
62A
Electrocardiographic infarct evolution is
accelerated by successful thrombolysis.
63A
Hemorrhagic myocardial infarction after
thrombolytic therapy: intraoperative
observations. 62A
Intravenous thrombolytic therapy in acute
myocardial infarction-six month
followup: the NHLBI thrombolysis in
myocardial infarction (TIMI) trial. 60A
Is ST segment elevation a valid ECG
criterion for thrombolysis selection in
acute myocardial infarction. 6IA
Lack of specificity of early post
thrombolytic arrhythmias as a
reperfusion marker in acute myocardial
infarction, 191 A
Prevention of late ventricular dilatation after
myocardial infarction by successful
thrombolysis. 6 lA
Sustained improvement of myocardial
perfusion three months after
thrombolysis assessed by thallium 201.
173A
Thrombolytic therapy in acute myocardial
infarction-six month followup: the
NHLBI thrombolysis in myocardial
infarction (TIMI) trial. 60A
Thrombolytic treatment of acute myocardial
infarction with intracoronary
administration of plasminogen pro-
activator. 190A
Thrombosis
Intracoronary thrombosis: a multi-focal
disease entity. 174A
Management of patients with heparin
associated thrombocytopenia and
thrombosis requiring cardiac surgery.
85A
Thromboxane
Atherosclerotic arteries produce more
prostacyclin and thrornboxane than
normal arteries. 170A
Oxygen free radicals mediate arachidonate
induced platelet aggregation and
thromboxane B2 production. 2A
Thrombus
Direct observation of coronary thrombus
using a newly developed ultrathin
(l .2mm) flexible angioscope, 197A
Thyrotoxicosis
Are calcium antagonists as effective as beta
blockers for the treatment of
thyrotoxicosis? I64A
Tissue type plasminogen activator
See Plasminogen activator
Tocainide
Inefficiency of oral tocainide in sustained
ventricular tachycardia and fibrillation,
102A
Tomography, computed
See also Cine computed tomography
Assessment of aortic disease by ultrafast
computed tomography, 159A
Combined perfusion and functional imaging
of the left ventricle in patients with
recent myocardial infarction by ultrafast
computed tomography. 159A
Law of constant heart volume in humans: a
noninvasive assessment via x-ray cr.
MRI and echo. 38A
Tomography, positron emission
Assessment of regional myocardial oxygen
utilization by positron tomography with
" Cvacetatc, 73A
Assessment of relative coronary flow reserve
with dynamic positron emission
tomography and H2 150 . 160A
Comparison of positron tomography and
quantitative angiography in stenosis
analysis after acute thrombolysis and
angioplasty in evolving myocardial
infarction. 179A
Increased exogenous glycolytic flux in
ischemic myocardium determined by
positron emission tomography , 73A
Metabolic identification of stunned canine
myocardium by positron emsision
tomography, 73A
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Torsade de pointes
Effectiveness of magnesium sulfate in
torsade de pointes: a study of 9
patients, 24SA
Transplantation
See Cardiac transplantation
Transposition of the great arteries
Electrophysiologic studies after arterial
switch repair of d-transposition of the
great arteries. 16SA
Long-term exercise performance in
transposition of the great arteries. 16SA
Results of the management of patients with
transposition of the great arteries in
current era. 203A
Right and left ventricular function 10 years
after Mustard operation for
transposition of the great arteries, 204A
Tricuspid insufficiency
Pulsed Doppler echocardiographic detection
of tricuspid insufficiency in children.
I30A
Triclls,id regurgitation
Serial Doppler echocardiographic assessment
of tricuspid regurgitation following
repair of ventricular septal defect in
early infance: possible relation to
operative approach. 20SA
Tricuspitt stenosis
Assessment of tricuspid stenosis by Doppler
echocardiography, 237A
TricllSpid valve
What is the fate of the tricuspid valve
following palliative surgery for
hypoplastic left heart syndrome. 132A
Triglycerides
Are serum triglyceride levels a determinant
of tracking of high density lipoprotein
cholesterol? The Bogalusa Heart Study.
S4A
Triiodothyronine
Initial experience with triiodothyronine (n)
therapy in patients with low cardiac
output following open heart surgery,
7A
Ultrasound
See also Echocardiography
Contrast ultrasonography of the kidney: a
new method for in vivo evaluation of
renal perfusion, 21SA
Regional and transmural dependence of
cardiac cycle variability in ultrasonic
backscatter: effects of acute myocardial
ischemia. 21IA
Ultrasonic tissue characterization in man
with real-time quantitative backscatter
imaging and delineation of integrated
backscatter dependence on the cardiac
cycle. 212A
Urok inase
Ancrod enhances the thrombolytic effect of
urokinase and recombinant tissue-type
plasminogen activator. 13SA
Vltlve prostbeses
Antibiotic sterilization in the preparation of
homovital homograft values: is it
necessary", 89A
Aortic valve replacement using unstented
dura or calf pericardium: early and
medium term results. 8C
Assessment of the time course of primary
bioprosthetic valve failure, 90A
Balloon dilation valvuloplasty of
bioprosthetic valves in extracardiac
conduits. 76A
The Carpentier-Edwards supra-annular
porcine bioprosthesis- new generation
tissue valve with excellent clinical
performance. 91A
Diuretic use: a risk factor for mortality after
aortic valve replacement. 21A
Does depressed left ventricular systolic
function return to normal late after
aortic valve replacement for aortic
stenosis. !l3A
Frequency of unusually high transvalvular
Doppler velocities in patients with
normal prosthetic valves. 23!lA
Recent improvement in late survival after
double valve replacement and tricuspid
annuloplasty. 9 1A
Valve replacement in children: guidelines
for selection of prosthesis. IM A
Valvotomy
See also Mitral valvotomy; Surgery.
valvular; Valvuloplasty
Antegrade balloon valvotomy for aortic
stenosis. 14A
Cardiopulmonary exercise performance after
successful percutaneous mitral
valvulotomy. 19SA
Early and late effects of percutaneous
balloon mitral valvotomy on plasma
levels of atrial natriuretic factor. 33A
Noninvasive assessment of the results of
surgical aortic valvotomy in adults with
calcific aortic stenosis. !lA
Percutaneous double balloon mitral
valvotomy: results using different sized
balloon catheters. !l2A
Percutaneous double-balloon valvotomy in
adults. 24!lA
Valvular regurgitation
See also specific valve
Regurgitant volumes by color flow
overestimate injected volumes in an in
vitro model. IIOA
Valvuloplasty
See also Aortic stenosis: Mitral
valvuloplasty: Valvotomy
Balloon aortic valvuloplasty in patients with
low ventricular ejection fraction. 203A
Balloon dilatation valvuloplasty of
bioprosthetic valves in extracardiac
conduits. 76A
Doppler echocardiography before. during
and after aortic valvuloplasty. 21!lA
Double balloon technique for dilatation of
valvular or vessel stenosis in congenital
and acquired heart disease. 76A
Early follow-up of percutaneous
transluminal aortic valvuloplasty. 196A
Is mitral valvuloplasty applicable in North
America? lOA
Natural history of candidates for balloon
aortic valvuloplasty. 19SA
Percutaneous balloon valvuloplasty: acute
results and long term follow up. 14A
Percutaneous transseptal balloon mitral
valvuloplasty: the Chinese experience
in 21 patients. 83A
Vascular function
Differential H I and H2 receptor mediated
histamine responses of canine epicardia l
conductance and distal resistance
vessels. 210A
The effect of training on the physiologic and
structural indices of vascular function.
234A
In vivo and in vitro coronary vascular
reactivity in hyperlipidemic swine.
2 lOA
Minimal coronary vascular resistance in
atrial hypertrophy. 169A
Vasoconstriction
Calcium entry blockers and alpha-mediated
vasoconstriction: effect of verapamil
and nicadripine in human forearm,
IM A
Enhanced hypoxic pulmonary
vasoconstriction in hypertension. 243A
Vasodilation
The acute dynamic flow mediated nature of
large vessel vasodilation in humans.
S7A
Forearm vasodilator response of patients
with hypertrophic cardiomyopathy:
evidence of a diffuse disorder of
vascular smooth muscle. 230A
Paradoxical cutaneous vasodilation with
mental stress or deep breath. 242A
Potentiation of vasodilator response to
mental stress in severe heart failure.
42A
Vasodilating ability of severely
atherosclerotic coronary arteries:
evaluation by epicardial
echocardiography in the operating
room. IS7A
Videomicroscopic demonstration of
defective cholinergic arteriolar
vasodilation in atherosclerotic rabbit.
21 1A
Vasopressin
Receptor stimulated acceleration of
phosphatiadylinositol response enhances
atrial natriuretic polypeptide release in
isolated adult rat atrial myocytes. 134A
Vasovagal syndrome
Unexplained cardiac syncope-role of
vasovagal syndrome. lOA
Ventricle, left
Abnormal left ventricular mechanics and
shape in hypertension in the absence of
ventricular hypertrophy. 52A
Automated left ventricular mass. volume
and shape from three-dimensional
magnetic resonance imaging: in vitro
valdiation, 46A
Changes in left ventricular architecture, load
and function following pregnancy, 43A
Effects of intracoronary nifedipine and
nicardipine on left ventricular inotropy
and relaxation, 163A
Relations between left ventricular shape.
volume and mass in chronic aortic
regurgitation. 21A
Total left ventricular potential energy can
not be transformed into external
mechanical work. 39A
Ventricle. right
Effects of ventricular interaction on the
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relationship between free wall
dimensions and volume of the right
ventricle. 39A
Time course of resolution of pulmonary
hypertension and right ventricular
remodelling after cardiac
transplantation. 31A
Ventricular aneurysm
Noninvasive analysis of left ventricular
blood-flowdynamics in left ventricular
aneurysm by color flow mapping. 66A
Ventricular arrhythmias
See also Ventricular fibrillation; Ventricular
tachycardia
Do baseline clinical characteristics predict
initial response to antiarrhythmic
therapy. 71A
Frequency and significance of ventricular
arrhythmias in patients with reduced
ejection fraction (:5 30%). 225A
A multicenter, randomized trial on the
efficacy of amiodarone. flecainide and
propafenone in patients with cardiac
disease and complex ventricular
arrhythmias, 48A
Post-exercise ventricular arrhythmias
reduced by the calcium entry blocker.
diltiazem, 228A
Prevalenceand frequency of ventricular
arrhythmias in the two months
following myocardial infarction. 240A
Serial analysis of spontaneous and induced
ventricular arrhythmias in a canine
model of myocardial infarction. 91A
Significance of exercise-induced frequent or
repetitive ventricularectopic beats in
apparently healthy volunteers. 55A
The time course of the reduction of
ventricular arrhythmias during oral
amiodarone loading. 47A
Use of one hour ECG recordings to identify
patients with ventricular ectopy post
infarction and to assess therapy. 222A
Value of dose-titration in the Cardiac
Arrhythmia Pilot Study (CAPS). 70A
Ventricular defibrillation
See Defibrillation
Ventricular dilation
False-positive TL-20I defects in left bundle
branch block: relationship to left
ventricular dilatation. 139A
Prevention of late ventriculardilatation after
myocardial infarction by successful
thrombolysis. 61A
Ventricular dysplasia
Fulguration in ventricular tachycardia due to
right ventricular dysplasia: mean-term
results. 250A
Ventricular false tendons
Left ventricular false tendons and Still's
murmur of childhood: a causative
association. 128A
Ventricular fibrillation
See also Defibrillator: Defibrillation
Accuracy in the automatic detection of
ventricular fibrillation . 206A
Clinical outcome of patients who have early
ventricular fibrillation after myocardial
infarction. 240A
Factors predicting safe early hospital
discharge after treatment of ventricular
tachycardia of ventricular fibrillation
with amiodarone. 47A
Inefficacy of oral tocainide in sustained
ventricular tachycardiaand fibrillation .
102A
Predictive value and efficacy of programmed
electrical stimulation and Holter
monitoring in the management of
ventriculartachycardia and fibrillation
after myocardial infarction. I09A
Predictors of arrhythmic recurrence in
survivors of ventricular fibrillation
rendered free of inducible ventricular
tachycardia. 97A
Ventricularfibrillation amplitude predicts
ability to defibrillate. 152A
Ventricular filling
Abnormal ventricular filling in sickle cell
anemia.58A
Changes in wall thickness but not left
ventricularmass predict improvement
of diastolic filling in hypertension,
244A
Differing responses in ventricular filling .
loading and volumes during positive
end-expiratory pressure (PEEP). 41A
Doppler echocardiographic study of left
ventriculardiastolic filling in ischemia:
effect of reperfusion on mitral flow
velocity.214A
Doppler evaluation of left ventricular
diastolic filling function during
angioplasty. 213A
Dopplerevaluation of left ventricular filling
dynamics during coronary angioplasty,
213A
Doppler evaluation of left ventricular inflow
during transient myocardial ischemia.
213A
Effect of atrial pacing on left ventricular
diastolic filling measured by pulsed
Doppler echocardiography. 197A
Evaluation of left ventricular diastolic filling
in isolated aortic stenosis using Doppler
echocardiography. 17A
Impaired left ventriculardiastolic filling in
patients with coronary artery disease
and normal systolic function :
correlation for age effect. 6A
Nitrate resistance: failure of intravenous
nitrate to reduce elevated left
ventricular filling pressure in acute
myocardial infarction. a common and
unpredictable phenomenon. 23A
Normalization of right ventricular diastolic
filling after arterial switch procedure.
204A
Peak filling rate by radionuclide
angiography: effect of normalization
parameters. 4A
Prevalence of left ventricularhypertrophy
and diastolic filling abnormalities in
elderly patient with isolated systolic
hypertension, 244A
Relationship between left ventricular systolic
asynchrony and filling in patients with
coronary artery disease. 6A
Validation of Doppler echocardiographically
derived peak filling normalized to
stroke volume: a comparison with
radionuclide angiographic techniques.
16A
Ventricular function
See also Diastole
Acute antiarrhythmic effect of flecainide in
ventricular tachyarrhythmias in relation
to left ventricular function. 71A
Age dependent effect of verapamil on end-
diastolic left ventricular function in
patients with hypertrophic
cardiomyopathy. 118A
Beta-blocker therapy for patients with
ventricular lachyarrhythmias and
impaired left ventricular function. 71A
Can recruitable collaterals protect global left
ventricular function after abrupt
coronary occlusion. 149A
Cardiovascular reserve in idiopathicdilated
cardiomyopathy: influence of right
ventricular function. 41A
Changes in mitral flow velocity with
exercise: an index of stress induced
ischemia, 198A
Combined perfusion and functional imaging
of the left ventricle in patients with
recent myocardial infarction by ultrafast
computed tomography. 159A
Comparison of measurements of left
ventricular function during exercise by
firstpass and equilibrium techniques.
4A
Compensatory augmentation of normal
regional function following coronary
occlusion: relation to myocardial area at
risk and extent of ischemicdysfunction .
92A
Coronary collaterals preserve left ventricular
function: evidence in patients
undergoing coronary angioplasty, 158A
Depressed ventricular function in chronic
experimental mitral regurgitation. 40A
Determinants of left ventricular function
after emergent interventional therapy in
myocardial infarction: the role of
residual stenosis. 233A
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intravenous tissue plasminogen
activator therapy for acute myocardial
infarction, 191A
Improved left ventricularfunction following
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ablation of malignant supraventricular
and ventricular tachycardia, 249A
Intraoperative Nd:YAG laser
photocoagulative ablation of ventricular
tachycardia: observations relevant to
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